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Abstract
In this dissertation, I have developed several high dimensional inferences and computational methods
motivated by problems in genomics studies. It consists of two parts. The first part is motivated by
analysis of data from genome-wide association studies (GWAS), where I have developed an optimal false
discovery rate (FDR) con- trolling method for high dimensional dependent data. For short-ranged
dependent data, I have shown that the marginal plug-in procedure has the optimal property in controlling
the FDR and minimizing the false non-discovery rate (FNR). When applied to analysis of the
neuroblastoma GWAS data, this procedure identified six more disease-associated variants compared to
previous p-value based procedures such as the Benjamini and Hochberg procedure. I have further
investigated the statistical issue of sparse signal recovery in the setting of GWAS and developed a
rigorous procedure for sample size and power analysis in the framework of FDR and FNR for GWAS. In
addition, I have characterized the almost complete discovery boundary in terms of signal strength and
non-null proportion and developed a procedure to achieve the almost complete recovery of the signals.
The second part of my dissertation was motivated by gene regulation network construction based on the
genetical genomics data (eQTL). I have developed a sparse high dimensional multivariate regression
model for studying the conditional independent relationships among a set of genes adjusting for possible
genetic effects, as well as the genetic architecture that influences the gene expression. I have developed
a covariate adjusted precision matrix estimation method (CAPME), which can be easily implemented by
linear programming. Asymptotic convergence rates and sign consistency are established for the
estimators of the regression coefficients and the precision matrix. Numerical performance of the
estimator was investigated using both simulated and real data sets. Simulation results have shown that
the CAPME resulted in great improvements in both estimation and graph structure selection. I have
applied the CAPME to analysis of a yeast eQTL data in order to identify the gene regulatory network
among a set of genes in the MAPK signaling pathway. Finally, I have also made the R software package
CAPME based on my dissertation work.
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ABSTRACT
METHODS FOR HIGH DIMENSIONAL INFERENCES WITH APPLICATIONS
IN GENOMICS

Jichun Xie
T. Tony Cai, Hongzhe Li

In this dissertation, I have developed several high dimensional inferences and computational methods motivated by problems in genomics studies. It consists of two
parts. The first part is motivated by analysis of data from genome-wide association
studies (GWAS), where I have developed an optimal false discovery rate (fdr) controlling method for high dimensional dependent data. For short-ranged dependent
data, I have shown that the marginal plug-in procedure has the optimal property in
controlling the fdr and minimizing the false non-discovery rate (fnr). When applied to analysis of the neuroblastoma GWAS data, this procedure identified six more
disease-associated variants compared to previous p-value based procedures such as the
Benjamini and Hochberg procedure. I have further investigated the statistical issue
of sparse signal recovery in the setting of GWAS and developed a rigorous procedure
for sample size and power analysis in the framework of fdr and fnr for GWAS.
In addition, I have characterized the almost complete discovery boundary in terms
of signal strength and non-null proportion and developed a procedure to achieve the
almost complete recovery of the signals. The second part of my dissertation was motivated by gene regulation network construction based on the genetical genomics data
iv

(eQTL). I have developed a sparse high dimensional multivariate regression model
for studying the conditional independent relationships among a set of genes adjusting for possible genetic effects, as well as the genetic architecture that influences the
gene expression. I have developed a covariate adjusted precision matrix estimation
method (capme), which can be easily implemented by linear programming. Asymptotic convergence rates and sign consistency are established for the estimators of the
regression coefficients and the precision matrix. Numerical performance of the estimator was investigated using both simulated and real data sets. Simulation results
have shown that the capme resulted in great improvements in both estimation and
graph structure selection. I have applied the capme to analysis of a yeast eQTL data
in order to identify the gene regulatory network among a set of genes in the MAPK
signaling pathway. Finally, I have also made the R software package capme based
on my dissertation work.
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Chapter 1
Introduction
My dissertation focuses on the methods for high dimensional inferences with applications in genomics. Scientifically, it is motivated by the applications in genome-wide
association studies (GWAS) and genetical genomics experiments (eQTL). Statically,
it is related to detecting rare features for high dimensional data, including multiple
testing, signal detection and sparse precision matrix estimation. The dissertation
contains two main parts. The first part deals with the problems of multiple testing
and sparse signal detection for GWAS, which are further divided into two projects:
the sample size and power analysis for GWAS data and the optimal false discovery
rate control for dependent data. The second part discusses the sparse precision matrix estimation, motivated by the gene regulatory pathway construction based on the
eQTL experiments.
The first project for my dissertation discusses the sample size and power analysis for sparse signal recovery in GWAS studies. GWAS have successfully identified
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hundreds of novel genetic variants associated with many complex human diseases.
However, there is a lack of rigorous work on evaluating the statistical power for
identifying these variants. In this project, I consider the problem of sparse signal
identification in genome-wide association studies and present two analytical frameworks for detailed analysis of the statistical power for detecting and identifying the
disease-associated variants. I present an explicit sample size formula for achieving a
given false non-discovery rate (fnr) while controlling the false discovery rate (fdr)
based on an optimal false discovery rate procedure. The problem of sparse genetic
variants recovery is also considered. I establish a boundary condition in terms of
sparsity and signal strength for almost exact recovery of disease-associated variants
as well as nondisease-associated variants. A data-adaptive procedure is proposed to
achieve the bound. These results provide important tools for sample size calculation
and power analysis for large-scale multiple testing problems. The analytical results
are illustrated with a genome-wide association study of neuroblastoma.
The second project continues to address the multiple testing problems for the applications in GWAS studies. It considers the problem of optimal false discovery rate
control when the test statistics are dependent. An optimal joint oracle procedure,
which minimizes the false non-discovery rate subject to a constraint on the false discovery rate is developed. A data-driven marginal plug-in procedure is then proposed
to approximate the optimal joint procedure for multivariate normal data. It is shown
that the marginal procedure is asymptotically optimal for multivariate normal data
with a short-range dependent covariance structure. Numerical results show that the
marginal procedure controls fdr and leads to a smaller fnr than several commonly
2

used p-value based fdr controlling methods. The procedure is illustrated by an application to a GWAS of neuroblastoma. It identifies a few more genetic variates that are
potentially associated with neuroblastoma than several p-value based false discovery
rate controlling procedures.
In the third project, I consider the problem of sparse precision matrix estimation
and its application in genomics. A key problem in biomedical research is to elucidate
the complex gene regulatory network underlying complex traits such as common
human diseases. In genetical genomics (eQTL) experiments, gene expression levels
are often treated as quantitative traits that are subject to genetic analysis. The
data can provide important information on gene regulation and genetic networks.
In this project, I introduce a sparse high dimensional multivariate regression model
for estimating the conditional dependency structure between gene expression data
accounting for the genetic effects. The model allows the mean of gene expression
levels to depend on other variables such as genetic markers. The covariate adjusted
precision matrix estimation (capme) method is proposed to estimate both the genetic
architecture and the conditional dependency among the expression level. Asymptotic
convergence rates and sign consistency are established for estimators of the regression
coefficients and the precision matrix. Numerical studies are conducted to demonstrate
the performance of capme. Simulation shows that capme leads to a better result
in terms of smaller estimation error and better support recovery compare with its
competitors. We apply capme to analysis of a yeast eQTL data in order to identify
the gene regulatory network among a set of genes in the MAPK pathway. Compared
to existing methods, capme provides a network that is sparser and more interpretable.
3

I discuss these three projects in detail Chapters 2, 3 and 4, respectively. In Chapter
5, I summarize my dissertation and discuss the projects extended from my current
research.

4

Chapter 2
Sample Size and Power Analysis
for Sparse Signal Recovery in
Genome-wide Association Studies

2.1

Introduction

Genome-wide association studies have emerged as an important tool for discovering regions of the genome that harbor genetic variants that confer risk for complex diseases. Such studies often involve scanning hundreds of thousands of single
nucleotide polymorphism markers in the genome for identifying the genetic variants.
Many novel genetic variants have been identified from recent genome-wide association
studies, including variants for age-related macular degenerative diseases (Klein et al.
, 2005), breast cancer (Hunter et al. , 2007) and neuroblastoma (Maris et al. , 2008).

5

The Welcome Trust Case-Control Consortium has recently published a study of seven
diseases using 14, 000 cases and 3000 shared controls (Welcome Trust Case-control
Consortium, 2007) and has identified several markers associated with each of these
complex diseases. The success of these studies has provided solid evidence that the
genome-wide association studies represent a powerful approach to the identification
of genes involved in common human diseases.
Due to the genetic complexity of many common diseases, it is generally assumed that there are often multiple genetic variants associated with disease risk.
The key question is to identify true disease-associated markers from the multitude
of nondisease-associated markers. The most common approach for the analysis of
genome-wide association data is to perform a single marker score test derived from
the logistic regression model and to control for multiplicity of testing using stringent
criteria such as the Bonferroni correction (McCarthy et al. , 2008). Similarly, the most
commonly used approach for sample size/power analysis for such large-scale association studies is based on detecting markers of given odds ratios using a conservative
Bonferroni correction. However, the Bonferonni correction is often too conservative
for large-scale multiple testing problems, which can lead to reduced power in detecting disease-associated markers. Analytical and simulation studies by Sabatti et al.
(2003) have shown that the false discovery rate procedure of Bejamini & Hochberg
(1995) can effectively control the false discovery rate for the dependent tests encountered in case-control association studies and increase the power over more traditional
methods.

6

Despite the success of genome-wide association studies, questions remain as to
whether the current sample sizes are large enough to detect most or all of the disease
markers. This is related to power and sample size analysis and is closely related to
the problem of sparse signal detection and discovery in statistics. However, the issue
of power analysis has not been addressed fully for simultaneous testing of hundreds
of thousands of null hypotheses. Efron (2007) presented an important alternative
for power analysis for large-scale multiple testing problems in the framework of local
false discovery rate. Gail et al. (2008) investigated the probability of detecting
the disease-associated markers in case-control genome-wide association studies in the
top T largest chi-square values from the trend tests of association. The detection
probability is related to the false non-discovery and the T is related to the false
discovery, although these terms are not explicitly used in that paper.
The goal of the present paper is to provide an analytical study of the power and
sample size issues in genome-wide association studies. We treat the vector of the score
statistics across all the markers as a sequence of Gaussian random variables. Since
we expect only a small number of markers are associated with disease, the true mean
of the vector of score statistics should be very sparse, although the degree of sparsity
is unknown. Our goal is to recover those sparse and relevant markers. This is deeply
connected with hypothesis testing in the context of multiple comparisons and false
discovery rate controls. Both false discovery rate control and sparse signal recovery
have been areas of intensive research in recent years. Sun & Cai (2007) showed
that the large-scale multiple testing problem has a corresponding equivalent weighted
classification formulation in the sense that the optimal solution to the multiple testing
7

problem is also the optimal decision rule for the weighted classification problem. They
further proposed an optimal false discovery rate controlling procedure that minimizes
the false non-discovery rate. Donoho & Jin (2004) studied the problem of detecting
sparse heterogeneous mixtures using higher criticism, focusing on testing the global
null hypothesis vs. the alternative where only a fraction of the data comes from a
normal distribution with a common non-null mean. It is particularly important that
the detectable region is identified on the amplitude/sparsity plane so that the higher
criticism can completely separate the two hypotheses asymptotically.
In this paper, we present analytical results on sparse signal recovery in the setting
of case-control genome-wide association studies. We investigate two frameworks for
detailed analysis of the statistical power for detecting and identifying the diseaseassociated markers. In a similar setting as in Gail et al. (2008), we first present
an explicit sample size formula for achieving a given false non-discovery rate while
controlling the false discovery rate based on the optimal false discovery rate controlling
procedure of Sun & Cai (2007). This provides important results on how odds ratios
and marker allele frequencies affect the power of identifying the disease-associated
markers. We also consider the problem of sparse marker recovery, establishing the
theoretical boundary for almost exact recovery of both the disease-associated markers
and nondisease-associated markers. Our results further extend the amplitude/sparsity
boundary of Donoho & Jin (2004) for almost exact recovery of the signals. Finally,
we construct a data adaptive procedure to achieve this bound.

8

2.2

Problem setup and Score statistics based on
the logistic regression models

We consider a case-control genome-wide association study with m markers genotyped, where the minor allele frequency for marker i is pi . Let Gi = 0, 1, 2 be the
number of minor alleles at marker i for i = 1, . . . , m, where Gi ∼Bin(2, pi ). Assume
that the total sample size is n and n1 = rn and n2 = (1 − r)n are the sample sizes
for cases and controls. Let Y =1 for diseased and Y = 0 for nondiseased individuals.
Suppose that in the source population, the probability of disease is given by

logit{P(Y | Gi , i = 1, . . . , m)} = a +

m
X

Gi bi ,

i=1

where only a very small fraction of bi s are nonzero. Gail et al. (2008) showed that
for rare diseases or for more common diseases over a confined age range such as 10
years, for case-control population, if the markers are independent of each other, it
follows that
logit{P(Y | Gi )} = ai + Gi bi ,

(2.2.1)

approximately for i = 1, . . . , m. This implies that a logistic regression model can be
fitted for each single marker i separately, for i = 1, . . . , m.
Based on the well-known results of Prentice & Pyke (1979), the maximum likelihood estimation for a cohort study applied to case-control data with model (2.2.1)
yields a fully efficient estimate of bi and a consistent variance estimate. For a given
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case-control study, let j be the index for individuals in the samples, Yj be the disease
status of the jth individual and Gij be the genotype score for the jth individual at
the ith marker. The profile score statistic to test H0i : bi = 0 can be written as

U (bi ) =

X

Gij (Yj − Ȳ ),

j

where Ȳ =

Pn
j=1

Yj . In the following, we denote Pi0 , Ei0 , vari0 as the probability,

expectation and variance calculated under the null hypothesis H0i : bi = 0, and
Pi1 , Ei1 , vari1 as those calculated under the alternative hypothesis H1i : bi = 1. Under
H0i : bi = 0, Pi0 (Yj = y| Gij = g) = K I(y = 1) + (1 − K) I(y = 0), where I(.) is the
indicator function. We have Ei0 {U (bi )| Y } = 0, vari0 {U (bi )| Y } = 2pi (1−pi )r(1−r)n.
Under the alternative, if bi is known,

u1gi = Pi1 (Yj = 1| Gij = g) =

exp(ai + bi g)
,
1 + exp(ai + bi g)

u0gi = Pi1 (Yj = 0| Gij = g) =

1
,
1 + exp(ai + bi g)

where ai can be determined by

P2
g=0

u1gi P(Gij = g) = D, with D being the disease

prevalence and P(Gij = g) = p2i I(g = 2) + 2pi (1 − pi ) I(g = 1) + (1 − pi )2 I(g = 0).
Then, we have

uy,g,i P(Gij = g)
.
wygi = Pi1 (Gij = g| Yj = y) = P2
0
g 0 =0 uyg 0 i P(Gij = g )

10

Therefore,

Ei1 {U (bi )| Y } = r(1 − r)n{Ei1 (Gij | Yj = 1) − Ei1 (Gij | Yj = 0)},
vari1 {U (bi )| Y } = r(1 − r)n{(1 − r) vari1 (Gij | Yj = 1) + r vari1 (Gij | Yj = 0)},
(2.2.2)

where Ei1 (Gij | Yj = y) =

P2
g=0

gwygi , Ei1 (G2ij | Yj = y) =

P2
g=0

g 2 wygi , and

vari1 (Gij | Yj = y) = Ei1 (G2ij | Yj = y) − {Ei1 (Gij | Yj = y)}2 .

Let
Xi = U (bi )/[vari0 {U (bi ) | Y }]1/2
be the score statistic for testing the association between the marker i and the disease. If bi is known, then under H0i , Xi ∼ N(0, 1) and under H1i , Xi ∼ N(µn,i , σi )
asymptotically, where
½

µn,i = n

1/2

¾1/2
r(1 − r)
µi ≡ n
{Ei1 (Gij | Yj = 1) − Ei1 (Gij | Yj = 0)}, (2.2.3)
2pi (1 − pi )
½
¾1/2
(1 − r) vari1 (Gij | Yj = 1) + r vari1 (Gij | Yj = 0)
σi =
. (2.2.4)
2pi (1 − pi )
1/2

Given bi , pi , r and D, µn,i and σi can be determined. Note that the alternative mean
µn,i increases with the sample size n at the order

√

n. Intuitively, as the sample

size increases, it is easier to differentiate the signals and zeros. So the problem of
power/sample size analysis can be formulated as the sparse normal mean problem:
We have m score statistics Xi , i = 1, . . . , m, only a very small proportion ²m of them
11

have non-zero means, and the goal is to identify those markers whose score statistics
have non-zero means.

2.3

Marker Recovery Based on Controlling the False
Discovery Rate and False Non-Discovery Rate

2.3.1

Effect Size and False Discovery Rate Control

As in the work of Genovese & Wasserman (2002) and Sun & Cai (2007), we use
the marginal false discovery rate, defined as mfdr=E(N01 )/E(R), and marginal false
non-discovery rate, defined as mfnr=E(N10 )/E(S), as our criteria for multiple testing, where R is the number of rejections, N01 is the number of nulls among these
rejections, S is the number of non-rejections, and N10 is the number of non-nulls
among these nonrejections. Genovese & Wasserman (2002) and Sun & Cai (2007)
showed that under weak conditions, mfdr and fdr, mfnr and fnr are asymptotically the same in the sense that mfdr= fdr + O(m−1/2 ) and mfnr= fnr +
O(m−1/2 ). In the following, we use mfdr and mfnr for our analytical analysis.
However, to simplify the notation, we use fdr and fnr.
Consider the sequence of score statistics Xi , i = 1, . . . , m, as defined in the
previous section, where under H0i , Xi ∼ N(0, 1) and under H1i , Xi ∼ N(µn,i , σi2 ),
µn,i 6= 0, σi ≥ 1. Usually, µn,i and σi are different across different disease-associated
markers due to different minor allele frequencies and different effect sizes as measured by the odds ratios, see Eqs. (2.2.3) and (2.2.4). However, since most of the
12

markers in genome-wide association studies are not rare and the observed odds ratios
range from 1·2 to 1·5, we can reasonably assume that they are on a comparable scale.
In addition, for the purpose of sample size calculation, one should always consider
the worst case scenarios for all the markers , which leads to a conservative estimate
of the required sample sizes. To simplify the notation and analysis and to obtain
closed-form analytical results, we thus assume that all the markers considered have
the same minor allele frequency and all the relevant markers have the same effect
size. Specifically, we assume that under H1i , Xi ∼ N(µ, σ 2 ), σ ≥ 1. Suppose that the
proportion of non-null effects is ²m . Defining a sequence of binary latent variables,
θ = (θ1 , . . . , θm ), the model under consideration can be stated as follows:

θ1 , . . . , θm are independently and identically distributed as Bernoulli(²m ),

(2.3.1)

2

if θi = 0, Xi ∼ N(0, 1); and if θi = 1, Xi ∼ N(µ, σ ).

Assume that σ is known. Our goal is to find the minimum µ that allows us to
identify θ with the level of fdr asymptotically controlled at α1 and the level of fnr
asymptotically controlled at α2 . We particularly consider the optimal false discovery
rate controlling procedure of Sun & Cai (2007), which simultaneously controls the
fdr at α1 and minimizes fnr asymptotically. Different from the p-value-based false
discovery rate procedures, this approach considers the distribution of the test statistics
and involves the following steps:

i. Given the observation X = (X1 , . . . , Xm ), estimate the non-null proportion ²̂m
using the method in Cai & Jin (2010). This estimator is based on Fourier
13

transformation and the empirical characteristic function, which can be written
as ²̂m = 1 − m−(1−η)

Pm
i=1

cos{(2η log m)1/2 Xi }, where η ∈ (0, 1/2) is a tuning

parameter, which needs to be small for the sparse case considered in this paper.
Based on our simulations, η = 10−4 works well.
ii. Use a kernel estimate fˆ to estimate the mixture density f of the Xi ’s,

fˆ(x) = m−1+ρ

m
X

K{mρ (x − Xj )}, ρ ∈ (0, 1/2),

(2.3.2)

j=1

where K{.} is a kernel function and ρ determines the bandwidth. We use
ρ=1·34×m−1/5 as recommended by Silverman (1986), pages 40-43.
iii. Compute T̂i = (1 − ²̂m )ϕ(Xi )/fˆ(Xi ), where ϕ(.) is the standard normal density
function.
iv. Let
i

k = max{i :

1X
T̂(j) ≤ α1 },
i j=1

then reject all H(i) , i = 1, . . . , k. This adaptive step-up procedure considers the
average posterior probability of being null and is adaptive to both the global
feature ²m and local feature of ϕ(Xi )/f (Xi ).

The procedure has a close connection with a weighted classification problem. Consider the loss function
m
X
Lλ (θ, δ) =
{λ I(θi = 0)δi + I(θi = 1)(1 − δi )}.
i=1
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(2.3.3)

The Bayes rule under the loss function (2.3.3) is
½
¾
(1 − ²m )f 0 (Xi )
1
θi (λ) = I Λ(Xi ) =
<
,
²m f 1 (Xi )
λ

(2.3.4)

where f 0 (x) = ϕ(x; 0, 1) and f 1 (x) = ϕ(x; µ, σ 2 ). Sun & Cai (2007) show that the
threshold λ is a decreasing function of the level of fdr, and for a given level of
fdr α1 , one can determine a unique thresholding λ to ensure the level of fdr to be
controlled under α1 . The following theorem gives the minimal signal µ required in
order to obtain the pre-specified levels of fdr and fnr using this optimal procedure.
Theorem 2.3.1. Consider the model in Eq. (4.2.1) and the optimal oracle procedure
of Sun & Cai (2007). In order to control the level of fdr under α1 and the level of
ˆ where (ĉ, d)
ˆ are the
fnr under α2 , the minimum µ has to be no less than (σ 2 − 1)d,
root of the following nonlinear equations:




Φ(c − dσ) − Φ(−c − dσ) = (1 − c1 )/(c2 − c1 ),

(2.3.5)




Φ(−cσ − d) + Φ(−cσ + d) = c1 (c2 − 1)/(c2 − c1 ),

where Φ is the cumulative density function of the standard normal distribution, and

c1 =

α1 ²m
(1 − α2 )²m
, c2 =
.
(1 − α1 )(1 − ²m )
α2 (1 − ²m )

As discussed in Section 2.2, in genome-wide association studies, µ =

√

nµ1 , where

µ1 as defined in Eq.(2.2.3) can be determined by the effect of the marker, log odds ratio
b, the minor allele frequency p and the case/control ratio r. The following corollary
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provides the minimum sample size needed in case-control genome-wide association
studies in order to control the level of fdr and fnr.
Corollary 2.3.2. Consider a case-control genome-wide association study, with m
markers, a total sample size of n, with n1 = nr cases and n2 = (1 − r)n controls.
Assume that all the markers have the same minor allele frequency of pi = p and all
the relevant markers have the same log odds ratio bi = b. In order to control the
levels of fdr and fnr under α1 and α2 asymptotically, the minimum total sample
ˆ 2 − 1)/µ1 }2 , where dˆ is the root of Eq.(2.3.5), and µ1
size must be at least n = {d(σ
and σ1 are defined in Eqs. (2.2.3) and (2.2.4).
Corollary 2.3.2 gives the minimum sample size required in order to identify the
markers with minor allele frequency p and effective odds ratio of b with fdr less than
α1 and fnr less than α2 using the optimal false discovery rate controlling procedure
of Sun & Cai (2007). Since this procedure asymptotically controls the level of fdr
and minimizes the level of fnr, the sample size obtained here is a lower bound. This
implies that asymptotically, one cannot control both fdr and fnr using a smaller
sample size with any other procedure. In practice, α2 should be set to less than ²m ,
which can be achieved by not rejecting any nulls.

2.3.2

Illustration

As a demonstration of our analytical results, we present the minimum sample
sizes needed for different levels of fdr and fnr in Figure 2.1 for ²m = 2 × 10−4 ,
which corresponds to assuming 100 disease-associated markers. We assume a disease
16

prevalence of D=0·10. As expected, the sample size needed increases as the level of
fdr or the target level of fnr decreases. It also decreases with higher signal strength.
The levels of fnr presented in the plot are very small since it cannot exceed the
proportion of the relevant markers ²m . When m is extremely large, ²m is usually very
small. In Figure 2.1, ²m = 2 × 10−4 and the level of fnr we choose should be less
than ²m , since fnr=²m can be achieved by not rejecting any of the markers. Among
the 100 relevant markers, fnr=10−4 , 2 × 10−5 and 10−6 corresponds to an expected
number of nondiscovered relevant markers of fewer than 50, 10 and 0·5, respectively.
As a comparison, with the same sample size for fdr=0·05 and fnr=10−4 , 2 × 10−5
and 10−6 , the power of the one-sided score test using the Bonferonni correction to
control the genome-wide error rate at 0·05 is 0·22, 0·64 and 0·95, respectively. We
observe that the sample sizes needed strongly depend on the fnr and the effect size of
the markers, but are less dependent on the level of fdr. Similar trends were observed
for ²m = 2 × 10−5 , which corresponds to assuming 10 disease-associated markers.
We performed simulation studies to evaluate the sample size formula presented
in Corollary 2.3.2. We assume that m = 500, 000 markers are tested with 100 being
associated with disease, which corresponds to ²m = 2 × 10−4 . We first considered
the setting that all the 100 relevant markers have the same odds ratio on disease risk
with a minor allele frequency of 0·40. For a pre-specified fdr=0·05 and fnr=10−4 ,
we determined the sample size based on Corollary 2.3.2. We then applied the false
discovery rate controlling procedure of Sun & Cai (2007) to the simulated data and
examined the observed fdrs and fnrs. Table 2.1 shows the empirical fdrs and fnrs
over 100 simulations for different values of the odds ratios. We see that the empirical
17

fdrs and fnrs are very close to the pre-specified values, indicating that the sample
size formula can indeed result in the specified fdr and fnr.
Since our power and sample size calculation is derived under the assumption of
common effect sizes for all associated markers and independent test statistics, we also
evaluated our results under the assumption of short-range dependency and unequal
effect sizes. To approximately mimic the dependency structure among markers due to
linkage disequilibrium, we assumed a block-diagonal covariance structure for the score
statistics with exchangeable correlation of 0·20 for block sizes of 50. We simulated
marker effects with a mean odds ratio ranging from 1·20 to 1·50. For a given mean
odds ratio, we obtained the sample size and simulated the corresponding marker
effects by generating µn,i from N (4·40, 1·00). We then applied the false discovery rate
controlling procedure and calculated the empirical fdrs and fnrs for different mean
odds ratios. The results are presented in Table 2.1, indicating that the false discovery
rate controlling procedure can indeed control fdrs and obtain the pre-specified fnrs.

2.4
2.4.1

A Procedure for Sparse marker Recovery
Oracle Sparse Marker Discovery

Besides controlling the fdr and fnr, an important alternative in practice is to
control the numbers of false discoveries and false non-discoveries. One limitation
with the use of fdr and fnr in power calculations is that they do not provide a very
clear idea about roughly how many markers are falsely identified and how many are
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Total sample size
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1.20

1.50

1.20

1.30

0.10

0.15

0.20
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1000

Total sample size

12000
8000

0.05

1.50

Odds ratio

4000

Total sample size

Odds ratio

1.40

0.05

False discovery rate

0.10

0.15

0.20

False discovery rate

Figure 2.1: Minimum sample size needed for a given fdr and fnr for a genome-wide
association study with m = 500, 000 markers and the relevant markers proportion
²m = 2×10−4 . Assume that the case proportion r=0·40 and the minor allele frequency
p=0·40. Top left: fdr=0·05 and different values of odds ratio; top right: fdr=0·20
and different values of odds ratio; bottom left: odds ratio of 1·20 and different values
of fdr; bottom right: odds ratio of 1·50 and different values of fdr. For each plot,
the solid, dash and dot lines correspond to fnr=10−4 , 2×10−5 and 10−6 , respectively.
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missed until the analysis is conducted. In genome-wide association studies, the goal
is to make the number of misidentified markers, including both the false discoveries
and false non-discoveries, converge to zero when the number of the markers m and
the sample sizes are sufficiently large. In this section, we investigate the conditions
on the parameters µ = µm and ²m in model (4.2.1) that can lead to almost exact
recovery of the null and non-null markers. This in turn provides a useful formula for
the minimum sample size required for an almost exact recovery of disease-associated
markers.
Consider model (4.2.1) and a decision rule δi for i = 1, . . . , m. We define fd as
the expected number of null scores that are misclassified to the alternative, similarly,
fn as the expected number of non-null scores that are misclassified to null,

fd = E{

m
X

I(θi = 0)δi }, fn = E{

i=1

m
X

I(θi = 1)(1 − δi )}.

i=1

Define the loss function as

L(θ, δ) =

X

I(θi = 0)δi + I(θi = 1)(1 − δi ) =

i

X

I(θi 6= δi ),

(2.4.1)

i

which is simply the Hamming distance between the true θ and its estimate δ. Note
that E{L(θ, δ)} = fd + fn.
Under model (4.2.1), the Bayes oracle rule (2.3.4) with λ = 1, defined as

δor,i

¾
½
(1 − ²m )f 0 (Xi )
<1 ,
= I Λor (Xi ) =
²m f 1 (Xi )
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(2.4.2)

minimizes the risk E{L(θ, δ)} = fd + fn. We consider the condition on µm and ²m
such that this risk converges to zero as m goes to infinity, where the non-null markers
are assumed to be sparse. We calibrate ²m and µm as follows. Define

²m = m−β , β ∈ (1/2, 1),

(2.4.3)

which measures the sparsity of the disease-associated markers, and

µm = (2τ log m)1/2 ,

(2.4.4)

which measures the strength of the disease-associated markers. Here we assume that
the disease markers are sparse. We first study the relationship between τ and β so
that both fd and fn converge to zero as m goes to infinity.
Theorem 2.4.1. Consider model (4.2.1) and reparameterize ²m and µ = µm in terms
of β and τ as in Eqs. (2.4.3) and (2.4.4). For any γ ≥ 0, under the condition

τ ≥ {(1 + γ)1/2 + σ(1 + γ − β)1/2 }2 ,

(2.4.5)

the Bayes rule (2.4.2) guarantees both fd and fn converge to zero with the convergence rate 1/{mγ (log m)1/2 }.

Theorem 2.4.1 shows the relationship between the strength of the signal and the
convergence rate of the expected false discoveries and false non-discoveries. As expected, astronger non-zero signal leads to faster convergence of the expected number
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of false identifications to zero and easier separation of the alternative from the null.
In Eq. (2.4.5), when γ = 0, the convergence rate of fd and fn is the slowest,
1/(log m)1/2 . Letting σ → 1 yields the phase diagram in Figure 2.2, which is an
extension to the phase diagram in Donoho & Jin (2004). Three lines separate the
τ − β plane into four regions. The detection boundary

τ=





β − 1/2

(1/2 < β ≤ 3/4),




{1 − (1 − β)1/2 }2

(3/4 < β < 1),

separates the detectable region and the undetectable region, when µ exceeds the
detection boundary, the null hypothesis H0 : Xi ∼ N (0, 1), 1 ≤ i ≤ m and the alter(m)

native H1

: Xi ∼ (1 − ²m )N (0, 1) + ²m N (µ, 1), 1 ≤ i ≤ m separate asymptotically.

Above the estimation boundary
τ = β,

(2.4.6)

it is possible not only to detect the presence of nonzero means, but also to estimate
these means. These two regions were identified by Donoho & Jin (2004). Based on
Theorem 2.4.1, we can obtain the almost exact recovery boundary

τ = {1 + (1 − β)1/2 }2 ,

which provides the region that we can recover the whole sequence of θ with a very
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Figure 2.2: Four regions of the τ −β plane, where ²m = m−β represents the percentage
of the true signals and µm = (2τ log m)1/2 measures the strength of the signals.
high probability converging to one when m → ∞, since

P{

X

I(θi 6= δi )} ≤ E(kθ − δk22 ) ³ 1/(log m)1/2 ,

i

where “³” represents asymptotic equivalence. In other words, in this region, we can
almost fully classify the θi into the nulls and the non-nulls.
Note that in large-scale genetic association studies, µ =

√

nµ1 . Based on Theo-

rem 2.4.1, we have the following corollary.
Corollary 2.4.2. Consider the same model as in Corollary 2.3.2. If the sample size
·

{2(1 + γ) log m}1/2 + σ{2(1 + γ) log m + 2 log ²m }1/2
n≥
µ1
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¸2
,

then both fd and fn of the oracle rule converge to zero with convergence rate 1/{mγ (log m)1/2 }.

2.4.2

An Adaptive Sparse Recovery Procedure

Theorem 2.4.1 shows that the convergence rate 1/{mγ (log m)1/2 } can be achieved
using the oracle rule (2.4.2). However, this rule involves unknown parameters, ²m ,
f 1 (x) and f 0 (x), which need to be estimated. Estimation errors can therefore affect
the convergence rate. We propose instead an adaptive estimation procedure for model
(4.2.1) that can achieve the same convergence rate for fd and fn under a slightly
stronger condition than that in Theorem 2.4.1.
Note that the Bayes Oracle rule given in (2.4.2) can be rewritten as

δor,i

©
ª
= I (1 − ²m )f 0 (Xi ) < ²m f 1 (Xi ) = I

½

¾
f (Xi )
> 2(1 − ²m ) ,
f 0 (Xi )

(2.4.7)

where f (x) = (1 − ²m )f 0 (x) + ²m f 1 (x) is the mixture density of the Xi ’s. The density
f is typically unknown, but easily estimable. Let fˆ(x) be a kernel density estimate
based on the observations X1 , X2 , · · · , Xm , defined by Eq. (2.3.2). For i = 1, . . . , m,
if |Xi | > {2(1 + γ) log m}1/2 , then reject the null H0i : θi = 0; otherwise, calculate
Ŝ(Xi ) = fˆ(Xi )/ϕ(Xi ) and reject the null if and only if Ŝ(Xi ) > 2. Note that the
threshold value 2 is based on Eq. (2.4.7) since the proportion ²m is vanishingly small
in our setting.
The next theorem shows that this adaptive procedure achieves the same convergence rate as the optimal Bayesian rule under a slightly stronger condition.
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Theorem 2.4.3. Consider model (4.2.1) and reparameterize ²m = n−β and µ =
µm = (2τ log m)1/2 as in Eqs. (2.4.3) and (2.4.4). Suppose that the Gaussian kernel
density estimate fˆ, defined in Eq. (2.3.2), with ρ=1·34×m−1/5 is used in the adaptive
procedure. For any γ ≥ 0, if

τ > {(1 + γ)1/2 + σ(1 + γ − β)1/2 }2 ,

then the adaptive procedure guarantees that both fd and fn converge to zero with the
convergence rate 1/{mγ (log m)1/2 }.

2.4.3

An Illustration of Marker Recovery

As an illustration, the sample sizes needed to obtain an almost exact recovery of
the true disease-associated markers are presented in Figure 2.3 for ²m = 2 × 10−4
and ²m = 2 × 10−5 , which correspond to 100 and 10 disease-associated markers. We
assume a disease prevalence of D=0·10. We observe that a larger γ implies a faster
rate of convergence, and therefore also larger sample size required to the achieve the
rate. Generally speaking, the sample sizes in Figure 2.3 are much larger than those
in Figure 2.1, simply because almost exact recovery of the disease-associated markers
is a much stronger goal than controlling the fdr and fnr at some given levels. In
addition, for markers with the same effect size, it is easier to achieve full recovery of
the relevant markers for the sparser cases, see right plot of Figure 2.3.
We performed simulation studies to investigate how sample size affects the convergence rate of fd and fn. We considered the same setting as above, where the
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1.30

1.40

1.50

15000

25000
1.20

5000

Total sample size

25000
15000
5000

Total sample size

Table 2.1: Empirical fdr and fnr (10−4 unit) and their standard errors for the
optimal false discovery rate procedure based on 100 simulations where the sample
sizes are determined by Corollary 2.3.2 for the independent sequences with the same
alternative odds ratio for fdr=0·05 and fnr=10−4 .
Independent sequence with
Short-ranged dependent sequence
the same alternative odds ratios
with different alternative odds ratios
Odds ratio Empirical fdr Empirical fnr Empirical fdr
Empirical fnr
1·20
0·050 (0·028)
1·04 (0·10)
0·051 (0·030)
1·04 (0·10)
1·23
0·048 (0·028)
1·03 (0·12)
0·051 (0·032)
1·04 (0·11)
1·26
0·045 (0·030)
1·04 (0·11)
0·055 (0·033)
1·04 (0·11)
1·29
0·046 (0·030)
1·15 (0·13)
0·053 (0·031)
1·03 (0·11)
1·33
0·053 (0·033)
1·04 (0·11)
0·054 (0·032)
1·05 (0·10)
1·36
0·047 (0·029)
1·01 (0·13)
0·049 (0·029)
1·00 (0·12)
1·39
0·051 (0·030)
1·02 (0·11)
0·051 (0·033)
1·01 (0·11)
1·43
0·046 (0·033)
1·05 (0·12)
0·044 (0·029)
1·04 (0·11)
1·46
0·046 (0·027)
1·04 (0·10)
0·046 (0·025)
1·02 (0·11)
1·50
0·051 (0·027)
1·03 (0·13)
0·053 (0·033)
1·03 (0·12)

1.20

Odds ratio

1.30

1.40

1.50

Odds ratio

Figure 2.3: Minimum sample size required for almost exact recovery of the diseaseassociated markers for a case-control genome-wide association study with the number
of markers m = 500, 000, case proportion r=0·40, minor allele frequency p=0·40 for
all the markers. Left: the relevant markers proportion is ²m = 2 × 10−4 ; right: the
relevant markers proportion is ²m = 2 × 10−5 . For each plot, the solid, dash and dot
lines correspond to γ value of 0·00, 0·20 and 0·40.
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Table 2.2: The performances of the oracle (o) and adaptive (a) fd and fn controlling
procedures for varying sample sizes, where n is the theoretical sample size. For a
given γ, the average number of fd+fn and its standard error over 100 simulations
are shown for each sample size and odds ratio (or) combination.
γ=0
γ=0·2
or
0·8n
n
1·2n
0·8n
n
1·2n
o 0·77(0·89) 0·14(0·35) 0·02(0·14) 0·08(0·27) 0·00(0·00) 0·00(0·00)
1·20 a 3·08(3·11) 3·10(3·23) 2·51(3·04) 2·57(3·02) 3·12(3·24) 2·59(3·12)
o 0·57(0·79) 0·13(0·37) 0·01(0·10) 0·03(0·17) 0·00(0·00) 0·00(0·00)
1·30 a 3·93(4·22) 2·61(2·97) 2·92(3·36) 3·41(3·99) 2·66(3·00) 2·92(3·34)
o 0·50(0·72) 0·1(0·30) 0·04(0·20) 0·02(0·14) 0·00(0·00) 0·01(0·10)
1·40 a 3·31(3·30) 2·57(3·11) 2·89(3·45) 2·97(3·39) 2·55(3·11) 2·84(3·42)
number of markers m = 500, 000, case proportion r=0·40, minor allele frequency
p=0·40 for all the markers and the relevant markers proportion is ²m = 2 × 10−4 . For
a given odds ratio and a given γ parameter, we obtained the minimum sample size
n for almost exact recovery and evaluated the convergence rate of the oracle and the
adaptive procedures under different sample sizes. Table 2.3 shows the average number
of fd+fn over 100 simulations. We observed a clear trend of decrease of the fd+fn
as we increase the sample sizes for both the oracle and the adaptive procedures. For
the adaptive procedure, when the sample size is larger than the minimum sample
size, decrease in fd+fn is small since the minimum sample size has already achieved
almost exact recovery.
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2.5

Genome-wide Association Study of Neuroblastoma - Power Consideration

Neuroblastoma is a pediatric cancer of the developing sympathetic nervous system
and is the most common form of solid tumor outside the central nervous system. It is
a complex disease, with rare familial forms occurring due to mutations in paired-like
homeobox 2b or anaplastic lymphoma kinase genes (Mosse et al. , 2008), and several
common variations being enriched in sporadic neuroblastoma cases (Maris et al. ,
2008). The latter genetic associations were discovered in a genome-wide association
study of sporadic cases, compared to children without cancer, conducted at The Children’s Hospital of Philadelphia. After initial quality controls on samples and marker
genotypes, our discovery data set contained 1627 neuroblastoma case subjects of European ancestry, each of which contained 479,804 markers. To correct the potential
effects of population structure, 2575 matching control subjects of European ancestry were selected based on their low identity-by-state estimates with case subjects.
Analysis of this data set has led to identification of several markers associated with
neuroblastoma, including 3 markers on 6p22 containing the predicted genes FLJ22536
and FLJ44180 with allelic odds ratio of about 1·40 (Maris et al. , 2008), and markers in BARD1 genes on chromosome 2 (Capasso et al. , 2009) with odds ratio of
about 1.68 in high risk cases. The question that remains to be answered is whether
the current sample size is large enough to identify all the neuroblastoma-associated
markers.
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We estimated ²m = 2 × 10−4 using the procedure of Cai and Jin (2010) with the
tuning parameter η = 10−4 . A small value of η was chosen to reflect that we expect a
very small number of disease-associated markers. With this estimate, we assume that
there are 96 markers associated with neuroblastoma. For the given sample size and
number of markers to be tested, the top left plot of Figure 2.4 shows the minimum
detectable odds ratios for markers with different minor allele frequencies for various
levels of fdr and fnr. Note that fnr of 10−4 , 5 × 10−5 and 10−5 corresponds to an
expected number of nondiscovered markers of fewer than 48, 24 and 4·8, respectively.
This plot indicates that with the current sample size, it is possible to recover about
half of the disease-associated markers with an odds ratio around 1·4 and a minor
allele frequency of around 20%.
The top right plot of Figure 2.4 shows the minimum detectable odds ratios for
markers with different minor allele frequencies for almost exact recovery at different
rates of convergence as specified by the parameter γ, indicating that the current
sample size is not large enough to obtain almost exact recovery of all the diseaseassociated markers with odds ratio around 1·40.
The bottom panel of Figures 2.4 shows similar plots if we assume that ²m = 10−4 ,
which implies that there are 48 associated markers. This plot indicates that with the
current sample size, it is possible to recover most of the disease-associated markers
with odds ratio around 1·4 and minor allele frequency round 20% for fdr of 1% or
5%. However, the sample size is still not large enough to obtain almost exact recovery
of all disease-associated markers with odds ratio around 1·40.
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Figure 2.4: Power analysis for neuroblastoma genome-wide association study, where
the top two plots assume that ² = 2 × 10−4 , which corresponds to 98 relevant markers and the bottom two plots assume that ² = 10−4 , which corresponds to 49 relevant markers. Left panel: detectable odds ratios for markers with different minor
allele frequencies. For top left plot, the solid, dot, dash and dot-dash lines correspond to (fdr=5%, fnr=10−4 ), (fdr=1%, fnr=10−4 ), (fdr=5%, fnr=10−5 ), and
(fdr=1% and fnr=10−5 ), respectively. For bottom left plot, the solid, dot, dash and
dot-dash lines correspond to (fdr=5%, fnr=5 × 10−5 ), (fdr=1%, fnr=5 × 10−5 ),
(fdr=5%, fnr=5 × 10−6 ), and (fdr=1% and fnr=5 × 10−6 ), respectively. Right
panel: detectable odds ratios for markers with different minor allele frequencies for
almost exact recovery with different convergence rates determined by γ=0·10 (solid)
and 0·40 (dash).
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2.6

Discussion

Our work complements and differs from that of Zaykin & Zhivotovsky (2005) and
Gail et al. (2008). Both Zaykin & Zhivotovsky (2005) and Gail et al. (2008) based
their analyses on the individual marker p-values, aiming to evaluate how likely the
markers selected based on the p-value ranking are disease-associated. Although both
papers considered the issues of false positives and false negatives, neither links these
to fdr and fnr in a formal way. Our analysis is mainly based on the distribution
of the score statistics derived from the logistic regressions for case-control data and
is set up in the framework of multiple testing and sparse signal recovery. In the
setting of thousands of hypotheses, it is natural to consider the power and sample
size in terms of fdr and fnr, which correspond to type I and type II errors in single
hypothesis testing. In addition, we have derived an explicit sample size formula under
the assumption of fixed allele frequency and fixed common marker effect.
In presenting the results for genome-wide association studies, we made several
simplifications. First, we assumed that the score statistics were independent across
all the m markers. This obviously does not hold due to linkage disequilibrium among
the markers. However, we expect such dependency to be short-ranged and our recent
unpublished results show that the optimal false discovery rate controlling procedure
of Sun & Cai (2007) is still valid and remains optimal. The results and the sample
size formulae remain valid for such short-range dependent score statistics. Zaykin &
Zhivotovsky (2005) and Gail et al. (2008) showed that correlations of p-values within
linkage disequilibrium blocks of markers or among such blocks have little effect on
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selection or detection probabilities because such correlations do not extend beyond a
small portion of the genome. It is likely, therefore, that our results were also little
affected by such correlations. This was further verified in our simulation studies shown
in Table 2.1. Second, to simplify the presentation and the derivation and to obtain a
clean sample size formula as we presented in Corollary 2.3.2 and Corollary 2.4.2, we
assumed that all the markers had the same minor allele frequency and the effect sizes
of the relevant markers were the same. One can only employ simulations for power
analysis if the minor allele frequencies and the marker effects are all different. In fact,
the analytical results that were used to validate their simulations in Gail et al. (2008)
were also derived under the assumption of fixed allele frequency and fixed common
effect. As in most of the power calculations, in practice, one should consider different
scenarios in terms of minor allele frequencies and odds ratios.
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2.7

Proofs

We present the proofs of Theorem 1, Theorem 2 and Theorem 3. We use the
symbol “³” to represent asymptotic equivalence. If a ³ b, then a = O(b) and
b = O(a).
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Proof of Theorem 1.
When δi = 1, we have

(1 − ²m ) ϕ(Xi ; 0, 1)
1
< ,
2
²m ϕ(Xi ; µ, σ )
λ

which is equivalent to (Xi − µ)/σ ∈ (−∞, −c − dσ) ∪ (c − dσ, +∞), where

½



c =



d =

2
log
σ2 − 1

µ

λσ(1 − ²m )
²m

¶

µ2
+ 2
(σ − 1)2

¾1/2
,

µ
.
σ2 − 1

(2.7.1)

Since
Pm

P(δi = 1 | θi = 0)(1 − ²m )
≤ α1 ,
i=1 {P(δi = 1 | θi = 0)(1 − ²m ) + P(δi = 1 | θi = 1)²m }

mfdr = Pm

i=1

we have

Φ(−cσ − d) + Φ(−cσ + d) ≤ c1 {Φ(−c − dσ) + Φ(−c + dσ)},

(2.7.2)

where c1 = α1 ²m /{(1 − α1 )(1 − ²m )}. Similarly, since
Pm

P(δi = 0 | θi = 1)²m
≤ α2 ,
i=1 {P(δi = 0 | θi = 0)(1 − ²m ) + P(δi = 0 | θi = 1)²m }

mfnr = Pm

i=1

we have
Φ(cσ − d) − Φ(−cσ − d) ≥ c2 {Φ(c − dσ) − Φ(−c − dσ)},
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(2.7.3)

where c2 = (1 − α2 )²m /{α2 (1 − ²m )}. Setting (2.7.2) and (2.7.3) as equality and
ˆ be the solution of this equation,
simplifying them, we obtain Eq. (2.3.5). Let (ĉ, d)
ˆ 2 − 1).
then Eq. (2.7.1) leads to µ̂ = d(σ

2

Proof of Theorem 2
Define c and d as in Eq. (2.7.1). Since

fd = mP(δi = 1 | θi = 0)(1 − ²m ) = m(1 − ²m ){Φ(−cσ − d) + Φ(−cσ + d)},

in order for fd to converge to zero, −cσ + d should be negative and small enough. In
addition, since
·

¸1/2
©
ª 2{β(σ 2 − 1) + τ }
2
(2τ log)1/2
−β
+
−cσ + d = −σ 2
log σ(1 − m ) +
log m
σ −1
(σ 2 − 1)2
σ2 − 1
√ h
i
©
ª1/2
2
2
1/2
−σ β(σ − 1) + τ
+τ
(log m)1/2 ,
³ 2
σ −1

as m → ∞, −cσ + d < 0. Because Φ(−cσ − d) ≤ Φ(−cσ + d), we have

fd ³

m
1
ϕ(cσ − d) ³
· m1−C1 ,
cσ − d
(log m)1/2

where
C1 =

[σ{β(σ 2 − 1) + τ }1/2 − τ 1/2 ]2
.
(σ 2 − 1)2
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In order for fd to converge to zero with the rate 1/{mγ (log m)1/2 }, we require

1 − C1 ≤ −γ,

which leads to
τ ≥ {(1 + γ)1/2 + σ(1 + γ − β)1/2 }2 .
Similarly,

fn = mP(δi = 0 | θi = 1)²m = m²m {Φ(c − dσ) + Φ(−c − dσ)},

and
·

©
ª 2{β(σ 2 − 1) + τ }
2
c − dσ = 2
log σ(1 − m−β ) +
log m
σ −1
(σ 2 − 1)2
√
¢
¤
2 £ ¡ 2
³ 2
{β σ − 1 + τ }1/2 − στ 1/2 (log m)1/2 .
σ −1

¸1/2
−

σ(2τ log m)1/2
σ2 − 1

As m → ∞, in order for c − dσ < 0, we require {β(σ 2 − 1) + τ }1/2 < σ/τ 1/2 , which
implies τ > β. Then,

fn ³

1
m
ϕ(dσ − c) ³
· m1−β−C2 ,
dσ − c
(log m)1/2

where

h
C2 =

σ(τ )1/2 − {β(σ 2 − 1) + τ }
(σ 2 − 1)2
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1/2

i2
.

It is easy to show that





 1 − β − C2 ≤ −γ,



 τ > β,

©
ª2
is equivalent to τ ≥ (1 + γ)1/2 + σ(1 + γ − β)1/2 .

2

Proof of Theorem 3
Define S(x) = f (x)/ϕ(Xi ), S̃(x) = S(x)/(1 − ²m ). We have

P{Ŝ(Xi ) > 2 | θi = 0}
≤P[|Xi | > {2(1 + γ) log m}1/2 | θi = 0]
+ P[|Xi | ≤ {2(1 + γ) log m}1/2 , S̃(x) > 3/2 | θi = 0]
+ P[|Xi | ≤ {2(1 + γ) log m}1/2 , |Ŝ(Xi ) − S̃(Xi )| > 1/2 | θi = 0]
=(A) + (B) + (C).

We control (A), (B) and (C), respectively. First, we have

£
¤
(A) = 2Φ −{2(1 + γ) log m}1/2 ≤ Cm−1−γ /(log m)1/2 .

Using the same technique as the proof of Theorem 2.4.1, if

ª2
©
τ ≥ (1 + γ)1/2 + σ(1 + γ − β)1/2 ,

(B) ≤ P{S̃(Xi ) > 3/2 | θi = 0} = P{ΛOR (Xi ) < 2 | θi = 0} ≤ Cm−1−γ /(log m)1/2 .
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Consider the set Xi = {Xi : |Xi | ≤ {2(1 + γ) log m}1/2 }, for all Xi ∈ Xi ,

P{|Ŝ(Xi ) − S̃(Xi )| > 1/2 | Xi }
≤ P{|mŜ(Xi ) − mS(Xi )| + |mS(Xi ) − mS̃(Xi )| > m/2 | Xi },

and
|mS(Xi ) − mS̃(Xi )| =

m1−β f (Xi )
.
(1 − ²m )ϕ(Xi )

Since the alternative density can be modeled as a Gaussian location-scale mixture,
we have

µ
¶
L
X
1
X i − µl
f (Xi ) = (1 − ²m )ϕ(Xi ) +
ϕ
²m,l ,
σl
σl
l=1

where ²m,l is the mixture proportion, representing the probability that Xj is from
N (µl , σl )). Under the condition
©
ª2
µl ≥ τ (1 + γ)1/2 + σl (1 + γ − β 0 )1/2

0

and σl > 1 for all l = 1, . . . , L, f (Xi )/ϕ(Xi ) < mβ , for all Xi . Then,

0

|mS(Xi ) − mS̃(Xi )| ≤ 2m1−(β−β ) , β > β 0 .

Therefore, for m sufficiently large,

P{|Ŝ(Xi ) − S̃(Xi )| > 1/2 | Xi ∈ Xi } ≤ P{|mŜ(Xi ) − mS(Xi )| > m/3 | Xi }.
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Let h = m−ρ , we have
Z
E{mŜ(Xi ) | Xi } − mS(Xi ) = m

K(y)
f (Xi )
f (Xi − yh) dy − m
.
ϕ(Xi )
ϕ(Xi )

Further, we take K(y) = ϕ(y) or any other symmetric kernel with a smaller tail
than ϕ when |y| > {2(1 + γ) log m}1/2 . Using the fact that
R

R

K(y) dy = 1 and

yK(y) dy = 0,
½Z
¾ (l)
X
f (Xi )
l l
l
.
E{mŜ(Xi ) | Xi } − mS(Xi ) = m
(−1) h
y K(y) dy
ϕ(Xi )
l=2

Let H l (x) be the lth Hermite Polynomial. For Xi ∈ Xi ,
¯ µ
¶¯
L
X
1 ¯¯ l Xi − µk ¯¯
l/2
|(−1) f (Xi )/ϕ(Xi )| ≤ (1−²m )|H (Xi )|+²m
H
¯ ≤ C(log m) .
l+1 ¯
σ
σ
k
k=1 k
l (l)

l

Therefore, for m sufficiently large,

P{|Ŝ(Xi ) − S̃(Xi )| > 1/2 | Xi }
≤P[|mŜ(Xi ) − mE{S(Xi ) | Xi }| + |E{mŜ(Xi ) | Xi } − mS(Xi )| > m/3 | Xi ]
≤P[|mŜ(Xi ) − mE{S(Xi ) | Xi }| + Cm1−2ρ log m > m/3 | Xi ]
≤P[|mŜ(Xi ) − mE{S(Xi ) | Xi }| > m/4 | Xi ].
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Let Xkl = (Xk , . . . , Xl ), l ≥ k. For example, X1m = (X1 , . . . , Xm ) = X. Given
Xi ∈ Xi , define

³
´
m K Xi −Xj
X
h
1
g(X) =
= Ŝ(Xi ),
h j=1
ϕ(Xi )

then
¯ ¡
¯
#
"
¾2
½
¯ K Xi −Xk ¢ ¯ 1
1 − 2h2
h
1
1 − h2
¯
¯
2
h
Xi −
Xk − 2
Xk ≤ .
¯
¯ ≤ exp −
2
2
2
¯ hϕ(Xi ) ¯ h
2h
1−h
2h (1 − h )
h

For k 6= i,
¯ ¡
¯
¯ K Xi −Xk ¢ − K ¡ Xi −x̃k ¢ ¯ 2
¯
¯
m
m
h
h
|g(X1k , Xk , Xk+1
) − g(X1k , x̃k , Xk+1
)| = ¯
¯≤ .
¯
¯ h
hϕ(Xi )

By McDiarmid’s inequality (McDiarmid, 1989),

P{|Ŝ(Xi ) − S̃(Xi )| > 1/2 | Xi with Xi ∈ Xi }
≤ P[|mŜ(Xi ) − mE{S(Xi ) | Xi }| > m/4 | Xi with Xi ∈ Xi ] ≤ 2 exp(−m1−2ρ /8).

Therefore,
Z
2 exp(−m1−2ρ /8)ϕ(Xi ) dXi ≤ 2 exp(−m1−2ρ /8).

(C) ≤
Xi ∈Xi

Thus,
fd = m(1 − ²m )P{Ŝ(Xi ) > 2 | θi = 0} ≤ Cm−γ /(log m)1/2 .
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Similarly,

fn = m²m P{Ŝ(Xi ) ≤ 2 | θi = 1}
= m1−β P{Ŝ(Xi ) ≤ 2, |Xi | ≤ {2(1 + γ) log m}1/2 | θi = 1}
≤ m1−β [P{S(Xi ) ≤ 5/2 | θi = 1}
+ P{|Ŝ(Xi ) − S̃(Xi )| > 1/2, |Xi | ≤ [2(1 + γ) log m]1/2 | θi = 1}]
= m1−β {(D) + (E)}.

Using the same technique as the proof of Theorem 2.4.1, if

©
ª2
τ ≥ (1 + γ)1/2 + σ(1 + γ − β)1/2 ,

then (D) ≤ Cm−1+β−γ /(log m)1/2 . Finally,
Z
P{|Ŝ(Xi ) − S̃(Xi )| > 1/2 | Xi }f 1 (Xi ) dXi ≤ 2 exp(−m1−2ρ /8).

(E) ≤
Xi ∈Xi

Thus,
fd = m(1 − ²m ) = m{(D) + (E)} ≤ Cm−γ /(log m)1/2 .
2
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Chapter 3
Optimal False-Discovery Rate
Control for Dependent Data

3.1

Introduction

False discovery rate control, introduced in the seminal paper by Bejamini &
Hochberg (1995), is one of the most important methodological developments in multiple hypothesis testing. Although the original false discovery rate controlling procedure
was developed for independent p-values, Benjamini & Yekutieli (2001) showed that
one can control the false discovery rate by the p value-based procedure under a certain positive dependency assumption, and thus demonstrated that the p-value based
procedure can be adaptive to certain dependency structure. The result has recently
been generalized to a family of step-up procedures that still control the false discovery
rate under more general dependency among the p-values (Blanchard & Fleuret, 2006;
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Sarkar, 2008; Blanchard & Roquain, 2009). When the proportion of the true nulls is
relatively small, these procedures are often conservative. To overcome this drawback,
adaptive plug-in procedures have been developed by incorporating an estimator of the
unknown proportion of the nulls in the threshold of the previous procedures (Storey
et al. , 2004; Benjamini et al. , 2006; Blanchard & Roquain, 2009).
The focus of these new procedures is mainly on controlling the false discovery
rate when the test statistics or the p-values are dependent. However, efficiency issue
has not been studied in these papers. Efron (2007) used local false discovery rate
to carry out both size and power calculations on large-scale testing problems. Efron
(2010) further investigated the issue of correlated z-values and accuracy of large-scale
statistical estimates under dependency. Sun & Cai (2007) developed an adaptive multiple testing rule for false discovery rate control and showed that such a procedure is
optimal in the sense that it minimizes the false non-discovery rate while controlling
the false discovery rate. In particular, the marginal false discovery rate and marginal
false non-discovery rate are used as the criteria for multiple testing, where the marginal false discovery rate is defined as mfdr=E(N10 )/E(R), the proportion of the
expected number of nulls (N10 ) among the expected number of rejections (R), and
marginal false non-discovery rate is defined as mfnr=E(N01 )/E(S), the proportion
of the expected number of non-nulls among the expected number of non-rejections
(S). Genovese & Wasserman (2002) showed that under the independence assumption, mfdr and fdr (mfnr and fnr) are asymptotically the same in the sense that
mfdr = fdr + O(m−1/2 ), where m is the number of hypotheses being tested. It will
be shown in Section 3.2 that such asymptotic equivalence holds in a more general
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setting.
Sun & Cai (2009) considered the case where the underlying latent indicator variable of being the null follows a homogenous irreducible hidden Markov chain and obtained an asymptotically optimal rule under this hidden Markov model. In this paper,
we consider the problem of optimal fdr control for general dependent test statistics.
Consider m null hypotheses and let θi take value 0 if the ith null hypothesis is true and
1 otherwise. The null hypotheses can then be written as H0i : θi = 0 (i = 1, . . . , m).
To test these hypotheses, one has a sequence of test statistics x = (x1 , . . . , xm ), which
represents a realization of a random vector X where

i.i.d.

X | θ ∼ g(x | θ), with θi ∼ Bernoulli(p),

i = 1, . . . , m.

(3.1.1)

We first present an oracle decision rule under this general model for dependent
statistics. Our development follows that of Sun & Cai (2007) by showing that the
large-scale multiple testing problem has a corresponding equivalent weighted classification problem in the sense that the optimal solution to multiple testing is also the
optimal decision rule for weighted classification. However, our development does not
require the monotone likelihood ratio condition for such an equivalence. In particular, let I{.} or I(.) be the indicator function, Sun & Cai (2007) focused on a class of
decision rules

S = {δ(x) : δi (x) = I{Ti (x) < ci }, where T (xi ) has monotone likelihood ratio}.

43

It was shown that the optimal solution to the weighted classification problem is optimal in S for the multiple testing problem. Our results show that the optimal solution
to the weighted classification problem is optimal among all decision rules for multiple
testing. Based on the classification rule, the optimal oracle rule for multiple testing
under the dependency model (3.1.1) is obtained.
We further consider the case when X follows a multivariate normal distribution,
where the observation x has the following distribution,

i.i.d.

X | θ ∼ N (µ | θ, Σ) , θi ∼ Bernoulli(p),

i = 1, . . . , m.

(3.1.2)

where µ | θ is the conditional mean vector and Σ is the covariance matrix. Under this
model and the short-range dependency of Σ, the marginal oracle statistics are shown
to be a uniformly consistent approximation to the joint oracle statistics. The marginal
oracle statistics are much easier to compute than the joint oracle statistics. We also
develop a data-driven marginal plug-in procedure and establish its optimality for the
fdr control. Extensive simulations and an application to a genome-wide association
study of neuroblastoma are presented to demonstrate the numerical properties of this
marginal plug-in procedure. The numerical results show that the marginal procedure
controls false discovery rate and leads to a smaller false non-discovery rate than several
commonly used p-value based false discovery rate controlling methods.
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3.2

Oracle Decision Rule for Multivariate Test Statistics

In this section, we develop an oracle decision rule for multiple testing under dependence using a compound decision-theoretic framework. Consider m null hypotheses
H0i , i = 1, ..., m and let θi take value 0 if the ith null hypothesis is true and 1 otherwise. In this paper we shall assume that θ1 , . . . , θm are independent and identically
distributed Bernoulli variables with success probability p. Let X = (X1 , . . . , Xm ) be
a sequence of test statistics for the m null hypotheses H0i : θi = 0 with the following
density,
x | θ ∼ g(x | θ).

(3.2.1)

Based on an observation of X: x = (x1 , . . . , xm ), the goal is to construct a multiple
testing procedure δ = (δ1 , . . . , δm ) which achieves the minimum mfnr while controlling mfdr at a prespecified level α. Due to the dependency among the Xi ’s, the
marginal distribution of Xi now depends not only on θi but the whole sequence of θ.
As in Sun & Cai (2007) for the independent case, our goal is to develop in the
dependent case a multiple testing procedure which minimizes the marginal false nondiscovery rate while controls the marginal false discovery rate. As mentioned in the
introduction, Genovese & Wasserman (2002) showed that under the independence
assumption, mfdr and fdr (mfnr and fnr) are asymptotically the same in the sense
that mfdr = fdr + O(m−1/2 ). The following theorem shows that the asymptotic
equivalence between the FDR and the mFDR holds in a more general short-range
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dependence setting.
Theorem 3.2.1. Suppose that X = (X1 , . . . , Xm ) is a sequence of random variables
with the same marginal density f and the short range dependency, so that Xi and Xj
are independent if |i − j| > mτ , for 0 ≤ τ < 1. Let δ̂i = I(Si ∈ R) be a short-ranged
rule to test H0i , in the sense that Si only depends on the variables that are dependent
with Xi ,
Si = S(Xi−bmτ c , . . . , Xi+bmτ c )

(0 ≤ τ < 1).

Further suppose that

P(Si ∈ R, θi = 1) ≥ P(Si ∈ R, θi = 0),

P(Si ∈ R, θi = 1) > 0 (i = 1, . . . , m).

Then the fdr (fnr) of the rule δ̂ can be approximated by the mfdr (mfnr),

lim (fdr − mfdr) = 0,

lim (fnr − mfnr) = 0.

m→∞

m→∞

It has been shown that the multiple testing problem is equivalent to a weighted
classification problem in the independent case (Sun & Cai, 2007) and under the
dependency specified by the hidden Markov model (Sun & Cai, 2009). We consider
the corresponding weighted classification problem under the model (3.2.1) and have
the following theorem.
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Theorem 3.2.2. Define the loss function:

Lλ (δ, θ) =

1 X
{δi I(θi = 0) + λ(1 − δi ) I(θi = 1)} .
m i

(3.2.2)

Consider the model defined in (3.2.1). Suppose that p and g are known. Then the
classification risk E{Lλ (θ, δ)} is minimized by the Bayes rule δ(Λ, λ) = (δ1 , . . . , δm ),
where
½
¾
(1 − p)g(x | θi = 0)
δi = I Λi (x) =
<λ
pg(x | θi = 1)

(i = 1, . . . , m).

(3.2.3)

The minimum classification risk is
Z
Rλ (δ(Λ, λ)) = p +

{(1 − p)g(x | θi = 0) − λpg(x | θi = 1)} dx,
K

where K = {x ∈ Ω : (1 − p)g(x | θi = 0) < λpg(x | θi = 1)}.

The rule given in Theorem 3.2.2 is optimal for the weighted classification problem.
We next show that the optimality property can be extended to the multiple testing
problem. Consider the optimal rule δ(Λ, λ) as defined in (3.2.3). Let Gsi (t) = P(Λi ≤
t | θi = s), s = 0, 1, be the conditional cumulative density functions (cdf) of Λi (x).
The cdf of Λi (x) is then given by Gi (t) = P(Λi ≤ t) = (1 − p)G0i (t) + pG1i (t).
Define the average conditional cdf’s of Λ, Gs (t) = (1/m)

Pm
i=1

Gsi (t) and average

conditional probability density functions of Λ, g s (t) = ( d/ dt)Gs (t), s = 0, 1. The
following theorem shows that Λ is also optimal for multiple testing.
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Theorem 3.2.3. Let Ds = {δ : δi = I(Λi < λ), i = 1, · · · , m}, where Λi ’s are defined
in (3.2.3). Given an mfdr level α and a decision rule

δ(S, R) = {I(S1 (x) ∈ R1 ), . . . , I(Sm (x) ∈ Rm )}

with mfdr{δ(S, R)} ≤ α, then there exists a λ determined by δ(S, R), such that
δ(Λ, λ) ∈ Ds outperforms δ(S, R) in the sense that

mfdr{δ(Λ, λ)} ≤ mfdr{δ(S, R)} ≤ α,

mfnr{δ(Λ, λ)} ≤ mfnr{δ(S, R)}.

Theorem 3.2.3 reveals that the optimal solution for the multiple testing problem
belongs to the set Ds . Instead of searching for all decision rules, one only needs to
search in the collection Ds for the optimal rule. The following result shows that for
a given mfdr value α, the optimal rule for the multiple testing problem is unique.
Theorem 3.2.4. Consider the optimal decision rule δ(Λ, λ) in (3.2.3) for the weighted
classification problem with the loss function (3.2.2). There exists a unique λ(α), such
that δ{Λ, λ(α)} controls mfdr at level α and minimizes mfnr among all decision
rules.

Theorem 3.2.4 shows that there exists a one-to-one mapping between the mfdr
value α and the thresholding λ, which determines the optimal rule. However, it is
often hard to obtain the corresponding λ(α) for a given α, in which case we need to
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develop an oracle rule that depends on α directly instead of λ(α). Define

Tor,i =

(1 − p)g(x| θi = 0)
,
g(x)

(3.2.4)

and, clearly Tor,i = Λi /(1 + Λi ) and increases with Λi . Thus, for a given mfdr value
α, one can rewrite the optimal oracle rule (3.2.3) as

δor,i

Let Rλ̃ =

Pm
i=1

½
= I Tor,i < λ̃(α) =

I(Tor,i < λ̃)/m, Vλ̃ =

Pm
i=1

λ(α)
1 + λ(α)

¾
.

(3.2.5)

I(Tor,i < λ̃, θi = 0)/m and Qλ̃ = Vλ̃ /Rλ̃ .

Then,

mfdr = E(Qλ̃ ) = E{E(Vλ̃ /Rλ̃ | x)}
(P
!
)
Ã PmR
m
λ̃
T
I(T
<
λ̃)T
or,(i)
or,i
or,i
i=1
i=1
=E
,
=E
P
m
mRλ̃
i=1 I(Tor,i < λ̃)
where Tor,(i) is the ith order statistic of Tor,i (i = 1, . . . , m). Suppose the number of
rejections is k = mR, then the false discovery proportion is controlled at α if
k

1X
Tor,(i) ≤ α.
k i=1

(3.2.6)

P
If for every k, (3.2.6) is satisfied, then mfdr = E( R
i=1 Tor,(i) /R) ≤ α.
Based on the argument presented above, we have the following joint oracle procedure for multiple testing with dependent statistics.
Theorem 3.2.5. Consider the model defined in (3.2.1). Suppose that p and g are
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known. Define Tor,i as in (3.2.4). Then the following procedure controls mfdr at
level α:
(

Reject all H(i)

)
l
1X
(i = 1, . . . , k), where k = max l :
Tor,(i) ≤ α .
l i=1

(3.2.7)

The final oracle rule (3.2.7) consists of two steps: the first step is to calculate
the oracle statistics Tor = (Tor,1 , . . . , Tor,m ), and the second step is to rank the
statistics and calculate the running averages from the smallest to the largest in order
to determine the cutoff. We then reject all the hypotheses with Tor,(i) below the
cutoff.

3.3

Marginal Approximation to the Joint Oracle
Procedure For Multivariate Normal Data

3.3.1

Marginal Oracle Rule

Theorems 3.2.3 - 3.2.5 show the optimality of the joint oracle rule for multivariate test statistics. However, the oracle rule assumes that the non-null proportion
p and the distribution g(x| θ) are both known. Even if g(x| θ) is known, it is still
computationally challenging to calculate g(x| θi = 0) and the mixture distribution
g(x) =

P
θ1 ,...,θm

g(x | θ). The computational complexity to obtain T or is O(m2m ).

To resolve the computational difficulty associated with the oracle rule, we show
in the following section that under the multivariate normal model (3.2.1) with short50

range dependence covariance structure, certain marginal oracle statistics can be used
to approximate the joint oracle statistics, which leads to a computationally feasible
optimal mfdr controlling procedure.
We make the following additional assumptions on the model (3.2.1):

(A). The non-null proportion goes to zero: limm→∞ p(m) = 0.
(B). The data x(m) = (x1 , . . . , xm ) is an observation of the random variable X (m) =
(X1 , . . . , Xm ), which follows a multivariate normal distribution given the latent
variable θ (m) = (θ1 , . . . , θm ),
³
´
X (m) | θ (m) ∼ N µ(m) | θ (m) , Σ(m) ,

(3.3.1)

where (µ(m) | θ (m) ) = (µ1 | θ1 , . . . , µm | θm ). The variable µi | (θi = 0) follows a
point mass distribution at point 0 and µi | (θi = 1) follows the distribution with
(m)

cdf F 1 (µ). Without loss of generality, assume X is re-scaled so that Σii

= 1.

Under this model, Xi has the same unknown marginal probability density
Z
f (x) =

ϕ(x − µ) dF (µ), where F (µ) = (1 − p)I(µ ≥ 0) + pF 1 (µ).

(C). The minimum eigenvalue of Σ(m) is bounded away from 0: limm→∞ λmin (Σ(m) ) =
κ > 0.
(m)

(D). The correlation structure of X (m) is short ranged with Σik
|i − k| ≥ mτ for some constant τ ∈ (0, 1).
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= 0 whenever

Define
Tmg,i = (1 − p)f (xi | θi = 0)/f (xi )

(3.3.2)

to be the marginal oracle rule, which only involves the marginal distributions of xi .
The following theorem shows that as m → ∞, Tmg,i can approximate Tor,i well.
Theorem 3.3.1. Under the assumptions (A) - (C), let Tor,i and Tmg,i be defined as
in equation (3.2.4) and equation (3.3.2). Then for all ² > 0 and for all i = 1, . . . , m,

lim P(| Tmg,i − Tor,i | > ²) = 0.

m→∞

Theorem 3.3.1 reveals that the marginal oracle statistics T mg = (Tmg,i , · · · , Tmg,m )
are a uniformly consistent approximation to the joint oracle rule determined by T or .
Note that T mg in Theorem 3.3.1 is a separable rule with a computation complexity
of O(m), much smaller than the complexity of the joint oracle rule.

3.3.2

Estimating the Marginal Oracle Statistics

In model (3.3.1), the marginal densities f (xi )’s are the same for all i = 1, . . . , m,
as well as f (xi | θi ). From now on, we use f to denote the marginal density and let
f , f0 and f1 be the marginal density, marginal density under the null and marginal
density under the alternative for Xi . Denote estimator of f , f0 , and the non-null
proportion p as fˆ, fˆ0 and p̂. Let T̂mg,i = {(1 − p̂)fˆ0 (xi )/fˆ(xi )} ∧ 1.
For many multiple testing problems, the theoretical null distribution f0 for Xi
is typically known. In short-range dependency cases, Cai & Jin (2010) provided
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an estimator for p with the minimax convergence rate. Estimating f under the
assumptions (A) - (D) is not straightforward even when f is a normal mixture under
the assumption (B). However, it is easy to obtain a non-parametric density estimate
under the short-range dependency assumption. Suppose that the range of correlation
is B = mτ (0 ≤ τ < 1) as in assumption (B). Define K = m/B = m1−τ . We rank
each coordinate of x in the following way so that it becomes a matrix:

k=1

2

...

K

b=1

x1

xB+1 . . . x(K−1)B+1

2

x2

xB+2 . . . x(K−1)B+2

..
.

..
.

..
.

..

B

xB

x2B

...

.

(3.3.3)

..
.
xKB

To facilitate the discussion, in the remaining part of this subsection, we use double
subindex to denote xi , i.e. xb,k is x(k−1)B+b in the original vector notation. Note that
each row of (3.3.3) is an independent subsequence of x with length K = m1−τ .
Therefore, we can obtain a kernel estimator fˆb (x) based on xb,· = (xb,1 , . . . , xb,K ),
P
ˆ
b = 1, . . . , B. Define fˆ(x0 ) = B
b=1 fb (x0 )/B. Note that f is a mixture of normal
densities and therefore, it is infinitely differentiable. Van Der Varrt (1998) showed
that for any bounded a differentiable function f such that

R

|f (a) (z)| dz ≤ M , with

appropriately chosen bandwidth h = n−a/(1+2a) , where n is the sample size, for any
x0 , the kernel estimate fˆ(x0 ) can achieve the bound

E{fˆ(x0 ) − f (x0 )}2 ≤ Cn−2a/(1+2a) ,
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(3.3.4)

where C only depends on the true marginal density f , the Kernel function and the
bandwidth h. In our setting, set the sample size n = m/B = K. For each row
of (3.3.3), the kernel estimator fˆb (x) can attain the estimation upper bound (3.3.4).
Therefore,

E{fˆb (x0 ) − f (x0 )}2 ≤ CK −2a/(1+2a) = Cm−2a(1−τ )/(1+2a)

(b = 1, . . . , B).

P
ˆ
Define fˆ(x0 ) = B
b=1 fb (x0 )/B. When 0 ≤ τ < 1,
B
1 X
2
ˆ
E{f (x0 ) − f (x0 )} = 2
E{fˆb (x0 ) − f (x0 )}2 → 0.
B b=1

P
The kernel estimators of f (x0 ) can be written as fˆb (x0 ) = K
k=1 w(x0 , Xb,k )/K,
where w is the kernel function. Thus
K
B
B
1 XX
1 Xˆ
ˆ
w(x0 , Xb,k )
fb (x0 ) =
f (x0 ) =
B b=1
KB b=1 k=1

is the same as the kernel estimator viewing X1 , . . . , Xm as independent and identically
distributed.
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3.3.3

Asymptotic Validity and Optimality of the Marginal
Plug-in Procedure

After obtaining the estimators for p, f and f0 , we define the marginal plug-in
procedure as
(

Reject all H(i)

)
i
1X
(i = 1, . . . , k), where k = max i :
T̂mg,(j) ≤ α ,
i j=1

(3.3.5)

where T̂mg,(j) is the jth order statistic of T̂mg,j (j = 1, · · · , m).
The next theorem shows that the plug-in procedure (3.3.5) is asymptotically valid
and optimal in the sense that it asymptotically controls mfdr under the given level
α and minimizes mfnr.
Theorem 3.3.2. Assume θi follows Bernoulli (p) independently (i = 1, . . . , m). Let
x = (x1 , . . . , xm ) be dependent observations satisfying the Assumptions (A), (B) and
(C). Let p̂ be the consistent estimator of p, and fˆ, fˆ0 be estimators of f and f0
satisfying for all x0 , E{fˆ(x0 ) − f (x0 )}2 → 0 and E{fˆ0 (x0 ) − f0 (x0 )}2 → 0. Define
T̂mg,i = (1 − p̂)fˆ0 (xi )/fˆ(xi ). The plug-in procedure (3.3.5) asymptotically controls the
mfdr at the given level α and simultaneously minimizes the mfnr.
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3.4
3.4.1

Simulation Studies
Simulation 1: The Performance of the Marginal Oracle
Rule

In this section we evaluate the numerical performance of the marginal procedure.
In our simulations, we assumed a multivariate mixture normal model:

X | θ ∼ N (µ | θ, Σ) ,

(3.4.1)

where θi follows Bernoulli(p). We chose the parameters so that the Assumptions (A)
- (D) hold. All simulation results were based on 1,000 replications.
In the following simulations, we set the number of hypotheses as m = 6,000 and
assume that the covariance matrix Σ is a block-diagonal matrix with block size of
30. Within each block, the sub-precision matrix is a banded matrix with bandwidth
1, diagonal elements of 1 and off-diagonal elements of 0·2. We set µ(θi = 0) = 0.
We have developed an efficient computational algorithm to compute the joint oracle
statistics under the banded precision matrix assumption with computation complexity
of O(2B m), where B is bandwidth for the precision matrix. Our aim is to compare
the performance of the optimal oracle rule with the marginal oracle rule when the
true parameters are known.
We considered different settings of the parameters and present the results in Figure
3.1. Overall, we observe that the results from the marginal oracle rule are similar
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to those from the optimal joint oracle rule. Both procedures control the fdr at the
desired levels and have smaller mfnrs than the Benjamini and Hochberg procedure.
The upper left and upper right panels show the observed fdr versus the alternative
mean value for mfdr = 0·05, and p = 0·20 and p = 0·02, respectively, indicating that
the marginal oracle rule can indeed control fdr at the desired level. As expected,
the Benjamini and Hochberg procedure is quite conservative. The upper middle left
and right plots show the fnr as a function of the mfdr for µ(θi = 1) = 2·50, and
p = 0·20 and p = 0·02, respectively. The lower middle left and right plots show the
fnr versus the alternative mean value with mfdr = 0·05, and p = 0·20 and p = 0·02,
respectively. These plots indicate that the joint oracle and the marginal oracle rules
perform similarly, and both have smaller fnr than the bh procedure. Finally, the
bottom plot shows the fnr as a function of the non-null proportion p for mfdr = 0·05
and µ1 = 3·5. We observe that as p increases, the Benjamini and Hochberg procedure
becomes increasingly more conservative, but the marginal oracle rule still performs
almost as efficiently as the joint oracle rule.

3.4.2

Simulation 2: The Performance of the Plug-in Marginal Rule

In this simulation, we evaluated the performance of the marginal plug-in procedure and compared this with other p-value-based procedures, including Storey’s α
procedure (Storey et al. , 2004), two two-stage adaptive procedures of Blanchard &
Roquain (2009), the adaptive procedure of Benjamini et al. (2006) and the Benjamini

57

0.060
Empirical FDR

0.040

0.050

0.060
0.050
0.040
0.030

Empirical FDR

3.6

3.8

4.0

4.2

4.4

3.6

3.8

4.0

4.2

4.4

alternative mean

0.020
0.012

0.016

Empirical FNR

0.15
0.10
0.05

Empirical FNR

0.20

alternative mean

0.05

0.10

0.15

0.20

0.05

0.10
mFDR

0.008
0.000

0.004

Empirical FNR

0.06
0.04
0.02
0.00

Empirical FNR

0.20

0.012

mFDR

0.15

3.6

3.8

4.0

4.2

4.4

3.6

3.8

4.0

4.2

4.4

alternative mean

0.04
0.02
0.00

Empirical FNR

0.06

alternative mean

0.05

0.10

0.15

0.20

non−null proportion

Figure 3.1: Comparison of the joint oracle procedure (black circle), the marginal oracle
procedure (dark grey triangle) and the Benjamini and Hochberg procedure (grey plus sign).
The upper left: mfdr = 0·05, p = 0·2; the upper right: mfdr = 0·05, p = 0·02; the upper
middle left: µ1 = 2·5, p = 0·2; the upper middle right: µ1 = 2·5, p = 0·02; the lower middle
left: mfdr = 0·05, p = 0·2; the lower middle right: mfdr = 0·05, p = 0·02; the lower left:
µ1 = 3·5, mfdr = 0·05.
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and Horchberg procedure (Bejamini & Hochberg, 1995), in different settings, to evaluate their empirical fdr and fnr. We chose the Benjamini and Horchberg procedure
since it is the first and still one of the most widely used procedures for fdr control.
The Storey’s α procedure was chosen since Blanchard & Roquain (2009) compared
it with several other procedures and concluded that it is the best procedure among
them in terms of controlling fdr and increased power under both independent and
dependent settings. The procedures of Blanchard & Roquain (2009) and Benjamini
et al. (2006) were developed for dependent test statistics and chosen for comparisons.
In all simulations, we set m = 6, 000, where two thousand variables were generated
from a block-structured covariance with block size of 40, two thousand variables were
generated from a block-structured covariance of block size of 20, and two thousand
variables were generated independently. We generated µ(θi = 1) from distribution
0·8 Unif(−6, −3)+ 0·2 Unif(3, 6) and considered four different scenarios:

A1. p = 0·2 and within-block covariance matrix is randomly generated and is sparse.
For blocks of size of 40, the proportion of non-zero off-diagonal elements is about
0·03 and for blocks of size 20, the proportion of non-zero off-diagonal elements
is about 0·08. All the within-block covariance matrices are regularized so that
the condition number is equal to the block size.
A2. p = 0·02 and within-block covariance matrix structure is the same as Model A1.
A3. p = 0·2 and within-block covariance matrix is exchangeable with non-diagonal
elements of 0·2.
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A4. p = 0·2 and within-block covariance matrix is exchangeable with non-diagonal
elements of 0·8.

The empirical fdr comparison results are shown in Table 3.1. We observe that
the marginal plug-in procedure controls the fdr well when within-block correlation
is low or moderate. However, when the within-block correlation becomes high as
in Model A4, the marginal plug-in approach results in inflated fdr. This is due to
the use of kernel estimate of the marginal density when the correlations among the
observations are high. Although other procedures can control fdr at the desired
levels, the procedures of Blanchard & Roquain (2009) are too conservative in the
settings we considered.
We compared the fnr result in the moderate correlation setting where the marginal plug-in procedure can control fdr at the desired level and present the results
in Table 3.2. Within each block, the sub-covariance matrix was randomly generated and was sparse. We generated µ(θi = 1) from two point mass distribution
(p1 /p)δ(β1 ) + (p2 /p)δ(β2 ). The non-null proportion was p = p1 + p2 . We considered
four sets of models in order to compare the empirical fnr obtained from different
methods.
In Model B, we considered the empirical fnr versus mfdr level under two different
non-null proportions p = 0·2 (Model B1) and p = 0·02 (Model B2), respectively. We
set p1 = 0·8p, β1 = −3, p2 = 0·2p and β2 = 3. Under such settings, the two-stage
procedures of Blanchard & Roquain (2009) have lower fnr than the Benjamini and
Hochberg procedure because they are quite conservative. Other procedures have
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Table 3.1: Comparison of empirical fdr(10−2 unit) vs. mfdr(10−2 unit) of six different procedures, including the marginal plug-in procedure, the original Benjamini
& Hochberg’s procedure (bh), the Storey’s α procedure (storey), the Blanchard &
Roquain’s two stage procedure with Holm’s step-down for the first step (br I), and
the Blanchard & Roquain’s two stage procedure controlling the family-wise error rate
for the first step (br II) and the procedure of Benjamini et al. (2006) (bk).
Model
A1

A2

A3

A4

Method
mg
bh
storey
br I
br II
bk
mg
bh
storey
br I
br II
bk
mg
bh
storey
br I
br II
bk
mg
bh
storey
br I
br II
bk

1
1·00(0·31)
0·79(0·28)
0·98(0·30)
0·39(0·20)
0·39(0·20)
0·97(0·30)
1·03(1·07)
0·96(1·09)
0·98(1·11)
0·50(0·82)
0·50(0·82)
1·08(1·14)
0·98(0·31)
0·77(0·27)
0·94(0·30)
0·38(0·20)
0·38(0·20)
0·94(0·30)
1·06(2·33)
0·87(1·88)
0·89(1·90)
0·45(1·28)
0·45(1·28)
0·98(1·97)

3
3·07(0·50)
2·34(0·47)
2·89(0·52)
1·17(0·34)
1·17(0·34)
2·89(0·52)
3·21(1·72)
2·93(1·73)
2·97(1·74)
1·49(1·27)
1·49(1·27)
3·25(1·80)
3·09(0·56)
2·32(0·50)
2·88(0·56)
1·14(0·35)
1·14(0·35)
2·87(0·56)
3·88(4·74)
3·04(4·00)
3·10(4·06)
1·55(2·90)
1·55(2·90)
3·35(4·13)

mfdr
5
5·26(0·63)
3·94(0·57)
4·90(0·65)
1·95(0·42)
1·95(0·42)
4·90(0·65)
5·44(2·14)
4·86(2·22)
4·93(2·26)
2·38(1·64)
2·38(1·63)
5·29(2·29)
5·27(0·73)
3·93(0·64)
4·90(0·73)
1·95(0·46)
1·95(0·46)
4·89(0·72)
6·20(5·44)
4·68(4·59)
4·78(4·66)
2·33(3·21)
2·33(3·21)
5·10(4·69)
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7
7·45(0·75)
5·52(0·70)
6·87(0·81)
2·74(0·51)
2·74(0·51)
6·86(0·81)
7·87(2·35)
6·88(2·48)
6·97(2·51)
3·42(1·83)
3·42(1·83)
7·42(2·51)
7·45(0·82)
5·49(0·71)
6·86(0·81)
2·74(0·51)
2·74(0·51)
6·85(0·80)
8·79(6·47)
6·67(5·68)
6·80(5·78)
3·42(4·17)
3·42(4·17)
7·18(5·75)

9
9·61(0·80)
7·10(0·76)
8·85(0·86)
3·54(0·56)
3·54(0·56)
8·83(0·86)
10·33(2·71)
8·79(2·93)
8·92(2·94)
4·40(2·10)
4·40(2·10)
9·38(2·92)
9·72(0·97)
7·12(0·84)
8·89(0·95)
3·55(0·60)
3·55(0·60)
8·88(0·94)
11·63(7·02)
8·48(6·09)
8·65(6·18)
4·21(4·31)
4·20(4·30)
9·07(6·13)

smaller fnr than the Benjamini and Hochberg procedure especially when p is large.
The marginal plug-in method has the smallest fnr values.
Model C considered the fnr as a function of β2 under p = 0·2 (Model C1) and
p = 0·02 (Model C2), respectively, setting α = 0·05, β1 = −3, p1 = 0·1 and p2 =0·1.
Decrease in the empirical fnr of the marginal plug-in procedure becomes larger as the
alternative distribution becomes more asymmetric. This trend is confirmed in Model
D, where we set mfdr =0·05, β1 = −3, β2 = 3 and considered fnr as a function of p1
with p = 0·2 (Model D1) and p = 0·02 (Model D2), respectively. Compared to other
procedures, the marginal plug-in procedure resulted in higher efficiency when the
alternative marginal distribution was highly asymmetric. This is because all other
procedures are based on the p-values, which are the probabilities under the null,
ignoring the information from the alternative marginal distribution. The marginal
plug-in procedure compares the probability under the marginal null and marginal
alternative and therefore is more adaptive to the shape of the marginal alternative.
In Model E, we set β1 = −3, β2 = 3, p1 = p2 = 0·5p and considered fnr as a
function of the non-null proportion p. As p increases, the marginal plug-in procedure,
the Storey’s α procedure and the procedure of Benjamini et al. (2006) performed
more efficiently than the Benjamini and Hochberg procedure since all of them are
adaptive to the proportion of the non-nulls. The marginal plug-in method still gives
the smallest fnr values.
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Table 3.2: Comparison of empirical fnr(10−2 unit) vs. mfdr (Model B), β2 (Model
C), p1 (Model D) and p (Model E). See Table 3.1 for details of these six methods
compared.
Model
B1

Method
mg
bh
storey
br I
br II
bk
bh
storey
br I
br II
bk

C1

mg
bh
storey
br I
br II
bk
mg
bh
storey
br I
br II
bk

C2

D1

D2

E

mg
bh
storey
br I
br II
bk
mg
bh
storey
br I
br II
bk
mg
bh
storey
br I
br II
bk

0·01
12·79(0·35)
14·00(0·36)
13·62(0·37)
15·68(0·33)
15·68(0·33)
1·75(0·09)
1·79(0·09)
1·79(0·09)
1·86(0·07)
1·87(0·07)
1·78(0·09)
3
7·61(0·35)
9·00(0·38)
8·37(0·38)
11·31(0·38)
11·31(0·38)
8·53(0·40)
1·41(0·11)
1·48(0·12)
1·48(0·12)
1·63(0·11)
1·64(0·11)
1·47(0·12)
0
5·96(0·32)
9·00(0·38)
8·37(0·38)
11·30(0·38)
11·30(0·38)
8·53(0·39)
1·29(0·12)
1·48(0·12)
1·48(0·12)
1·64(0·11)
1·64(0·11)
1·47(0·12)
0·01
0·80(0·07)
0·81(0·07)
0·82(0·08)
0·87(0·06)
0·88(0·06)
0·80(0·08)

0·03
9·33(0·35)
10·73(0·39)
10·15(0·39)
12·88(0·37)
12·88(0·37)
1·54(0·10)
1·60(0·10)
1·60(0·11)
1·73(0·09)
1·73(0·09)
1·59(0·10)
3·75
3·60(0·26)
4·24(0·28)
3·79(0·28)
5·86(0·32)
5·86(0·32)
3·83(0·28)
1·16(0·11)
1·23(0·11)
1·23(0·11)
1·42(0·11)
1·42(0·11)
1·22(0·12)
0·25
7·80(0·34)
8·99(0·38)
8·36(0·38)
11·31(0·38)
11·31(0·38)
8·52(0·39)
1·36(0·12)
1·48(0·12)
1·48(0·12)
1·63(0·11)
1·63(0·11)
1·47(0·12)
0·07
3·95(0·21)
4·04(0·22)
3·98(0·22)
4·78(0·22)
4·78(0·22)
4·00(0·22)
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0·05
7·60(0·35)
9·01(0·39)
8·38(0·39)
11·31(0·38)
11·31(0·38)
1·41(0·11)
1·48(0·12)
1·48(0·12)
1·64(0·11)
1·64(0·11)
1·47(0·12)
4·5
1·93(0·18)
2·26(0·20)
2·02(0·19)
3·11(0·23)
3·11(0·23)
2·03(0·19)
0·92(0·10)
0·99(0·11)
0·99(0·11)
1·17(0·12)
1·17(0·12)
0·97(0·11)
0·5
8·22(0·36)
9·00(0·38)
8·37(0·38)
11·31(0·4)
11·31(0·4)
8·53(0·39)
1·40(0·11)
1·47(0·11)
1·47(0·11)
1·64(0·11)
1·64(0·11)
1·46(0·11)
0·13
6·15(0·27)
6·48(0·29)
6·22(0·29)
7·94(0·30)
7·94(0·30)
6·30(0·30)

0·07
6·42(0·34)
7·84(0·38)
7·17(0·38)
10·19(0·39)
10·19(0·39)
1·30(0·12)
1·38(0·12)
1·38(0·12)
1·56(0·11)
1·56(0·11)
1·37(0·12)
5·25
1·37(0·16)
1·78(0·18)
1·62(0·18)
2·32(0·19)
2·32(0·19)
1·62(0·18)
0·72(0·10)
0·78(0·10)
0·78(0·10)
0·95(0·11)
0·95(0·11)
0·76(0·10)
0·75
7·79(0·35)
9·00(0·39)
8·36(0·38)
11·30(0·38)
11·30(0·38)
8·53(0·39)
1·44(0·11)
1·48(0·12)
1·48(0·12)
1·64(0·11)
1·64(0·11)
1·47(0·12)
0·19
7·93(0·33)
8·63(0·35)
8·07(0·35)
10·83(0·35)
10·83(0·35)
8·22(0·36)

0·09
5·57(0·32)
6·96(0·36)
6·28(0·35)
9·37(0·38)
9·37(0·38)
1·23(0·11)
1·31(0·12)
1·31(0·12)
1·51(0·11)
1·51(0·11)
1·30(0·12)
6
1·18(0·15)
1·71(0·18)
1·56(0·18)
2·17(0·20)
2·17(0·20)
1·56(0·18)
0·56(0·09)
0·60(0·09)
0·59(0·09)
0·74(0·10)
0·74(0·10)
0·58(0·09)
1
5·96(0·31)
8·97(0·37)
8·34(0·37)
11·28(0·38)
11·28(0·38)
8·50(0·38)
1·46(0·11)
1·48(0·12)
1·48(0·12)
1·64(0·11)
1·64(0·11)
1·47(0·12)
0·25
9·49(0·38)
10·74(0·41)
9·71(0·40)
13·66(0·41)
13·66(0·41)
9·93(0·42)

3.5

Application to analysis of case-control genetic
study of neuroblastoma

We applied the proposed fdr controlling procedure to a case-control genetic study
of neuroblastoma conducted at the Children’s Hospital of Philadelphia. Neuroblastoma is a pediatric cancer of the developing sympathetic nervous system and is the
most common solid tumors outside the central nervous system. It is a complex disease, with rare familial forms occurring due to mutations in PHOX2B or ALK (Mosse
et al. , 2005, 2008), and several common variations being enriched in sporadic neuroblastoma cases (Maris et al. , 2008). The latter genetic associations were discovered
in a genome-wide association study of sporadic neuroblastoma cases, compared to
children without cancer, conducted at the Children’s Hospital of Philadelphia. After initial quality controls on samples and the marker genotypes, our discovery data
set contained 1627 neuroblastoma case subjects of European ancestry, each of which
contained 479,804 markers. To correct the potential effects of population structure,
2575 matching control subjects of European ancestry were selected based on their low
identity-by-state estimates with case subjects.
For each marker, a score statistic was obtained by fitting a logistic regression
model using an additive coding of the genotypes. Due to linkage disequilibrium
among the markers, these score statistics cannot be treated as independent. However,
despite existence of long-range linkage disequilibrium, the linkage disequilibrium in
general decay as the distance between two markers decreases (Kruglyak, 1999; ?).
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We therefore can reasonably assume that the score statistics across all the markers
are short-range dependent. To apply our proposed method, we used the method
of Cai & Jin (2010) to estimate p and used the kernel density estimation for the
marginal densities. We set different nominal mfdr values (mfdr ∈ [0·01,0·2]) and
examined the number of rejections based on the proposed marginal plug-in procedure
and several p-value based procedures (see Figure 3.2). For a given mfdr level, the
marginal plug-in procedure always identifies more significant markers than the bh
and other p-value based procedures that can account for dependency of the test
statistics, suggesting that it may lead to a smaller fnr and therefore better power
of detecting the neuroblastoma associated markers. This is especially important for
initial genome-wide scanning in order to identify the potential candidate markers for
follow-up studies.
The marginal plug-in procedure identified 30 markers that are associated with
neuroblastoma for mfdr = 0·05. In contrast, the Benjamini and Hochberg procedure identified 24 markers, the Storey’s α procedure identified 24 markers, and the
two stage procedures of Blanchard & Roquain (2009) and the adaptive procedure
of Benjamini et al. (2006) identified 21, 21 and 25 markers, respectively. The six
additional markers identified by our proposed marginal plug-in procedure, but missed
by the standard Benjamini and Hochberg procedure, are presented in Table 3.3. The
BARD1 gene provides instructions for making a protein that helps control cell growth
and division. Within the nucleus of cells, the BARD1 protein interacts with the protein produced from the BRCA1 gene. Together, these two proteins mediate DNA
damage response (Irminger-Finger & Jefford, 2006). This provides some biological
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Figure 3.2: Comparison of number of rejections vs the mfdr level for the marginal
plug-in procedure (circle) and the p-value based procedures, including the Storey’s α
procedure (upward triangle), the Blanchard & Roquain procedure with Holm’s step
down in the first step (plus sign), the Blanchard & Roquain procedure with familywise error control in step 1 (cross sign), the procedure of Benjamini et al. (2006)
(diamond) and the Benjamini and Hochberg procedure (downward triangle) for the
case-control neuroblastoma genome-wide association study.
evidence for the association between the BARD1 gene and neuroblastoma. In fact,
recent publication of Capasso et al. (2009) identified the variants in BARD1 tumor
suppressor gene influence susceptibility to high-risk neuroblastoma. Another gene,
DGKI, is known to regulate Ras guanyl-releasing protein 3 and inhibits Rap1 signaling (Regier et al. , 2005). However, the association between the variant in DGKI
gene and neuroblastoma is not clear and deserves further biological validation. Gene
XPO4, encodes a nuclear export protein whose substrate, EIF5A2, is amplified in
human tumors, is required for proliferation of XPO4-deficient tumor cells, and promotes hepatocellular carcinoma in mice (Zender et al. , 2008). Another gene IKZF1
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that encodes the lymphoid transcription factor IKAROS, has recently be reported
to be associated with the poor outcome in acute lymphoblastic leukemia (Mullighan
et al. , 2009), and was also discovered to harbor common variations associated with
susceptibility to this disease (?). The NR5A2 gene encodes a transcription factor that
has been discovered to be responsible for the reprogramming of differentiated cells
into stem cells. Stem cells generated from differentiated cells are known as induced
pluripotent stem cells (Heng et al. , 2010).
Table 3.3: Six single nucleotide polymorphism markers identified by the marginal
plug-in procedure, but missed by the Benjamini and Hochberg procedure for the
neuroblastoma data. Z score2 is the square of the score statistic from a logistic
regression with genotypes coded as 0, 1, and 2.
Marker
Gene
Chromosome Z score2 p-value
rs4770073 XPO4
13
21·74
3·13×10−6
rs7557557 BARD1 2
21·79
3·05×10−6
rs1714518 RSRC1
3
21·86
2·93×10−6
rs10248903 IKZF1
7
2·25
4·03×10−6
rs3828112 NR5A2
1
20·59
5·67×10−6
rs2059320 DGKI
7
20·42
6·21×10−6

3.6

Discussion

We have studied in this paper the multiple testing problem under the setting
where the test statistics are dependent. It is shown that for any multiple testing
problem under the dependent model (3.2.1), there exists a corresponding weighted
classification problem, such that the optimal decision rule for the classification problem is also an optimal solution to the multiple testing problem. Although the oracle
rule obtained is optimal under the dependent model (3.2.1), it is not easy to implement. A marginal oracle rule is shown to approximate the optimal joint oracle rule
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when the test statistics follow a multivariate normal distribution with short range
dependence. A data-driven marginal plug-in procedure is developed and is shown to
be asymptotically valid and optimal in such a setting.
It should be emphasized that the marginal plug-in procedure is not necessarily
the same as the adaptive compound decision rules. We showed that the marginal
density of Xi can be estimated by treating the data as independent. The procedure
we adopted here produces consistent estimator for the marginal density. However,
for dependent data, this might not be the optimal choice. It is an interesting future research topic to develop alternative estimation methods that can estimate the
marginal densities with a faster convergence rate. In addition, in order to show the
asymptotic optimality of the marginal plug-in procedure, we require Assumptions
(A)-(D). Among them, Assumptions (A) and (C) are necessary and cannot be weakened. For the dependency structure that does not satisfy either Assumption (A) or
(C), the marginal plug-in procedure does not have the asymptotic optimality. How to
obtain a practical and asymptotically optimal FDR controlling procedure under more
general dependency structure for test statistics is still a challenging open problem.

3.7

Proofs

We collect the proofs of the main theorems in this Appendix.

of Theorem 3.2.1. Define U0 =

Pm
i=1

I(Si ∈ R, θi = 0), U1 =

Pm
i=1

I(Si ∈ R, θi = 1).

Let V0 = E(U0 )/m = P(Si ∈ R, θi = 0) and V1 = E(U1 )/m = P(Si ∈ R, θi = 1). The
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mfdr and fdr can be written as

E(U0 )
V0
mfdr =
=
,
E(U0 + U1 )
V0 + V1

µ
fdr = E{Ψ(U0 , U1 )} = mE

U0
U0 + U1

¶
.

Let Ψ(y1 , y2 ) = y1 /(y1 +y2 ). By Taylor expansion, fdr = E{Ψ(U0 , U1 )} = mfdr+
(A) + (B), where

(A) =

1 ∂ 2Ψ
∂ 2Ψ
2
(V
,
V
)E{(U
−
mV
)
}
+
(V0 , V1 )E(U0 − mV0 )E(U1 − mV1 )
0
1
0
0
2 ∂ 2 y1
∂y1 ∂y2

1 ∂ 2Ψ
(V0 , V1 )E{(U1 − mV1 )2 },
2 ∂ 2 y2
X
1
(B) =
E{ζ(U0 , U1 , V0 , V1 )(U0 − V0 )k1 (U1 − V1 )k2 },
k
!k
!
1 2
k +k =3
+

1

2

with ζ(U0 , U1 , V0 , V1 ) =

R1
0

(1 − t)3

∂3Ψ

k
k
∂y1 1 ∂y2 2

(tU0 + (1 − t)mV0 , tU1 + (1 − t)mV1 ) dt.

We need to bound (A) and (B) respectively. For any k1 + k2 = k,
¯ k
¯
¯ ∂ Ψ(y1 , y2 )
¯
Ck!
¯
¯ ≤ Ck! max(mV0 , mV1 ) ≤
(V
,
V
)
,
0
1
¯ ∂y k1 ∂y k2
¯
k+1
(mV0 + mV1 )
(V0 + V1 )k mk
1
2

E{(U0 − mV0 )2 } =mE{(I{Si ∈ R, θi = 0} − V0 )2 }
+

m X
X

E{(I{Si ∈ R, θi = 0} − V0 )(I{Sj ∈ R, θj = 0} − V0 )}

i=1 j6=i

≤mV0 (1 − V0 ) + 4m1+τ .

The inequality is due to the fact that Si (i = 1, . . . , m) is short-ranged and the
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dependency structure of X is short-ranged, so that Si and Sj are independent if
|i − j| > 2mτ . Similarly, we can show that E{(U1 − mV1 )2 } ≤ Cm1+τ . Therefore, by
Cauchy–Schwarz inequality,

(A) ≤

C
{mV0 (1 − V0 ) + 2m1+τ } = C1 m−1+τ ,
(V0 + V1 )2 m2

where C1 depends on V0 and V1 .
For any k1 + k2 = k,
¯
¯
k
¯
¯
¯(1 − t)k ∂ Ψ(y1 , y2 ) (tU0 + (1 − t)mV0 , tU1 + (1 − t)mV1 )¯
¯
¯
k1
k2
∂y1 ∂y2
≤

Ck!(1 − t)k max{tU0 + (1 − t)V0 , tU1 + (1 − t)V1 }
{t(U0 + U1 ) + (1 − t)m(V0 + V1 )}k+1

≤©

Ck!
≤
.
ª
k
t
(V0 + V1 )k mk
(U
+
U
)
+
m(V
+
V
)
0
1
0
1
1−t
Ck!

Thus, |ζ(U0 , U1 , V0 , V1 )| ≤ C1 /mk .
Let W0,i = I(Si ∈ R, θi = 0) − V0 and W1,i = I(Si ∈ R, θi = 1) − V1 . We have

3

E{(U0 − mV0 ) } =

3
mE(W0,i
)

+

m X
X

2
E(W0,i W0,j
)

i=1 j6=i

+

m XX
X
i=1 j6=i l6=i,j

≤ m + m(4mτ ) + m(4mτ )(8mτ ) ≤ Cm1+2τ ,
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E(W0,i W0,j W0,l )

and

2

2

E{(U0 − mV0 )(U1 − mV1 ) } = m

2
E(W0,i W1,j
)

+

m X
m X
X

E(W0,i W1,j W1,l )

i=1 j=1 l6=j

≤ m2 + m2 (4mτ ) ≤ Cm2+τ .

Similarly, E{(U1 − mV1 )3 } ≤ Cm1+2τ and E{(U0 − mV0 )(U1 − mV1 )2 } ≤ Cm2+τ .
Therefore,
X

(B) =

k1 +k2

C1
E{(U0 − mV0 )k1 (U1 − mV1 )k2 } ≤ C1 m−1+τ .
3
m
=3

This leads to fdr = mfdr + 2C1 m−1+τ .
Following a similar argument, we can show that fnr = mfnr + 2C1 m−1+τ .
The proof of Theorem 3.2.2 follows that of Sun & Cai (2007) and ia omitted here.

of Theorem 3.2.3. Given the fdr level α, consider a decision rule δ(S, R), with
mfdr(δ(S, R)) ≤ α. Suppose that the expected rejection number for δ(S, R) is
r. For δ(Λ, λ) defined in (3.2.3), the expected number of rejections is
(
r(λ) = E

m
X

)
I(Λi < 1/λ)

= mpG1 (1/λ) + m(1 − p)G0 (1/λ).

i=1

Thus, r(λ) monotonically decreases with λ. In addition, it is easy to see that

lim {r(λ)/m} = 1,

λ→0
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lim r(λ) = 0.

λ→∞

Therefore, for a given rejection number r determined by δ(S, R), there exists a unique
λ(r) such that the rule δ(Λ, λ(r)) has the same rejection number.
For δ(S, R), suppose the expected false discovery number is vS and the true
discovery number is kS . Similarly, suppose vΛ and kΛ is the expected false and true
discovery number for δ(Λ, λ). Then r = vS + kS = vΛ + kΛ . Consider the loss function

Lλ(r) =

1 X
{λ(r)δi I(θi = 0) + (1 − δi ) I(θi = 1)} ,
m i

then the risk for δ(S, R) and δ(Λ, λ) is Rλ(r) = p + (1/m) {λ(r)vL − kL } ,

L = S, Λ.

Since Rλ(r) (δ(Λ, λ)) ≤ Rλ(r) (δ(S, R)), it implies that vΛ ≤ vS and kΛ ≥ kS .
Let mfdrL and mfnrL be the mfdr and mfnr of δ(S, R) and δ(Λ, λ), L = S, Λ.
Note that

mfdrL = vL /r and mfnrL = (m1 − kL )/(m − r),

L = S, Λ.

The fact that vΛ ≤ vS and kΛ ≥ kS leads to mfdrΛ ≤ mfdrS and mfnrΛ ≤
mfnrS .
The proof of Theorem 3.2.4 requires the following Lemma.
Lemma 3.7.1. Consider the oracle classification statistic Λ defined in (3.2.3). Let
g s (t), s = 0, 1 be the average conditional pdf ’s of Λ. Then g 1 (t)/g 0 (t) = (1 − p)/(pt).
That is, g 1 (t)/g 0 (t) is monotonically decreasing in t.

The proof of Lemma 3.7.1 is similar to the proof of Corollary 1 in Sun & Cai
72

(2009) and is omitted.

of Theorem 3.2.4. Note that Lemma 3.7.1 implies that
Z

c

ÁZ c
ÁZ
Z c
1
0
g (t) dt
g (t) dt <
g (t) dt

c

0

0

0

0

0

g 1 (c) 0
g (t) dt = g 0 (c)/g 1 (c),
0
g (c)

which is equivalent to g 1 (c)G0 (c) < g 0 (c)G1 (c). Similarly, we can get g 1 (c)(1 −
G0 (c)) > g 0 (c)(1 − G1 (c)).
Let c = 1/λ. We show that mfdr strictly increases with c.

mfdr =

E{

Pn

I(T ≤ c, θi = 0)}
i=1
Pm i
E { i=1 I(Ti ≤ c)}

P
0
(1 − p) m
(1 − p)G0 (c)
i=1 Gi (c)
P
=
=
.
m
G(c)
i=1 Gi (c)

The derivative

d
p(1 − p){g 0 (c)G1 (c) − g 1 (c)G0 (c)}
mfdr =
> 0.
dc
(G(c))2

Therefore, the mfdr strictly increases with c and therefore decreases with λ.
We can show that mfnr = p{1 − G1 (c)}/{1 − G(c)} and the derivative of mfnr
is {g 0 (c)(1 − G1 (c)) − g 1 (c)(1 − G0 (c))}/{1 − G(c)}2 < 0. Therefore, mfnr strictly
decreases with c and increases with λ.
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of Theorem 3.3.1. First, we have

| Tmg,i − Tor,i |
¯
¯¯
¯
¯
¯ (1 − p)f (xi | θi = 0) ¯ ¯ g(x−i | xi , θi = 0)
¯¯
¯
−
1
= ¯¯
¯¯
¯
f (xi )
g(x−i | xi )
¯
¯
¯ { g(x−i | xi , θi = 0) − g(x−i | xi , θi = 1) }P(θi = 1| xi ) ¯
¯
≤ ¯¯
¯
g(x−i | xi )
¯
¯
¯ pf (xi |θi = 1){ g(x−i | xi , θi = 0) − g(x−i | xi , θi = 1) } ¯
¯
= ¯¯
¯
g(x)
¯
¯
(m)
¯
¯
2p| Ωii |1/2
¯
¯
©
ª
≤¯ P
¯.
¯ θ exp − 12 (x − µ(θ))T Σ−1 (x − µ(θ)) P(θ) ¯

(m)

For m sufficiently large, λmin (Σ(m) ) > κ/2 and | Ωii | ≤ λmax (Ω(m) ) < 2/κ. For all
η > 0, there exists an l0 , such that P(|

P
θ

exp{− 21 (x − µ(θ))T Σ−1 (x − µ(θ))}P(θ)| <

√
√
l0 )) < η. For all ε > 0, there exists an m sufficiently large, such that 2 2p/( κε) < l0 .
Then for all i = 1, . . . , m,

P(| Tmg,i − Tor,i | > ²)
¯
Ã¯
!
¯X
¯
£
¤
¯
¯
=P ¯
exp −{x − µ(θ)}T Σ−1 {x − µ(θ)}/2 P(θ) ¯ < l0 < η.
¯
¯
θ

The proof of Theorem 3.3.2 requires the following two lemmas.
Lemma 3.7.2. Assume Assumptions (A), (B) and (C) hold. Let p̂, fˆ, and fˆ0 be
estimates such that p̂ converges to p in probability, and for all x, E{fˆ(x)−f (x)}2 → 0
and E{fˆ0 (x) − f0 (x)}2 → 0, then T̂mg,i converges to Tor,i in probability.
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The proof of Lemma 3.7.2 is similar to the proof of Lemma A.1 and A.2 in Sun
& Cai (2007) and is omitted.
Lemma 3.7.3. Let R̂λ =

1
m

Pm
i=1

I(T̂mg,i ≤ λ) and V̂t =

1
m

Pm
i=1

I(T̂mg,i ≤ t)T̂mg,i .

Define Q̂λ = V̂λ /R̂λ . Then for α < t < 1, Q̂λ converges to Qλ in probability.
of Lemma 3.7.3. Let νi = E{I(Tor,i < λ)} and Zi = I(Tor,i < λ) − νi . On {x :
|Tor,i − Tmg,i | ≤ ε}, I(Tor,i < λ) = I(Tmg,i < λ) holds unless λ − ε ≤ Tmg,i ≤ λ + ε.
Therefore, for any ε > 0,

|E{I(Tor,i < λ)} − E{I(Tmg,i < λ)}| ≤ P(|Tor,i − Tmg,i | > ε) + P(λ − ε < Tmg < λ + ε).

The first term converges to zero uniformly by Theorem 3.3.1, and the second term
converges to zero uniformly by the continuity of Tmg . Consequently, νi → P(Tmg < λ)
uniformly. The short range dependency structure of X leads to the short range
dependency structure of Z, and consequently

var(Z̄) = var(Zi )/m +

m X
X

cov(Zi , Zj )/(m2 ) ≤ 1/m + m−1+τ → 0.

i=1 j6=i

By weak law of large numbers of triangle arrays, we have Z̄ converges to 0 in probability. Thus,
m

|Rλ − P(Tmg

1 X
< λ)| ≤
|νi − P(Tmg < λ)| + |Z̄| → 0.
m i=1

Similarly, we write R̂λ as R̂λ =

Pm

i=1 {I(T̂mg,i

75

< λ) − P(T̂mg < λ)} + P(T̂mg < λ). The

first part goes to 0 by the weak law of large numbers for triangle arrays, and the
second part goes to P(Tmg < λ). Then we have R̂λ converges to Rλ in probability.
We next prove V̂λ converges to Vλ in probability. For any ε > 0, if m is sufficiently
large, for all i, E(Tor,i − Tmg,i ) ≤ ε + P(|Tor,i − Tmg,i | > ε) < 2ε. Therefore, E(Tor,i ) →
E(Tmg ) uniformly. We then have

E{Tor,i I(Tor,i < λ)} − E{Tmg I(Tmg < λ)} ≤ P(|Tor,i − Tmg | > ε)
+ E(Tor,i − Tmg ) + P(λ − ε ≤ Tmg ≤ λ + ε).

All three parts go to zero uniformly as m → ∞. Similar to the convergence of Rλ
shown above, we can obtain that Vλ converges to E{Tmg I(Tmg < λ)} in probability.
We can show similarly that V̂λ converges to E{Tmg I(Tmg < λ)} in probability. Then
V̂λ converges to Vλ in probability. Consequently, we conclude that Q̂λ = V̂λ /R̂λ
converges to Vλ /Rλ = Qλ in probability.
of Theorem 3.3.2. Define threshold λ = sup{t ∈ (0, 1) : Q(t) ≤ α} and the plug-in
threshold λ̂ = sup{t ∈ (0, 1) : Q̂(t) ≤ α}. Since Q̂λ converges to Qλ in probability, by
Lemma A.5 in Sun & Cai (2007), we have λ̂ converges to λ in probability. The plug-in
procedure is equivalent to rejecting H0i when T̂mg,i ≤ λ̂. In the proof for Lemma 3.7.3,
we have

Pm
i=1

P(Tor,i < λ)/m → P(Tmg < λ) and

1
m

Pm
i=1

P(Tor,i < λ | H0i ) converges

to P(Tmg < λ | H0i ) in probability. Following the same arguments, T̂mg,i − λ̂ → Tmg,i −λ
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uniformly, and thus
m

1 X
P(T̂mg,i < λ) → P(Tmg < λ),
m i=1

m

1 X
P(T̂mg,i < λ | H0i ) → P(Tmg < λ | H0i ).
m i=1

It follows that
m

m

1 X
1 X
P(T̂mg,i < λ̂ | H0i ) −
P(Tor,i < λ | H0i ) → 0,
m i=1
m i=1
m

m

1 X
1 X
P(T̂mg,i < λ̂) −
P(Tor,i < λ) → 0.
m i=1
m i=1
Consequently,
P
(1 − p) m
P(T̂mg,i < λ̂ | H0i )
=
Pmi=1
ER̂λ̂ )
i=1 P(T̂mg,i < λ̂)
P
0
(1 − p) m
E (Vλ )
i=1 P(Tor,i < λ | Hi )
=
→
= mfdror .
Pm
E (Rλ )
i=1 P(T̂or,i < λ)

E(V̂λ̂ )

Following a similar argument, we can show that E(V̂λ̂ )/E(R̂λ̂ ) → mfnror .

77

Chapter 4
Covariate Adjusted Precision
Matrix Estimation with an
Application in Genetical Genomics

4.1

Introduction

It has now been well-established that gene expression levels are inheritable and
can be viewed as quantitative traits in both model organisms and in human. The
genetic loci that control the gene expressions are therefore referred as expression
quantitative trait loci (eQTL) (Jansen & Nap, 2001). Gene expression data, together
with the genetical variants information, have provided important insights into gene
expression regulations in both model organisms and in human (Brem & Kruglyak,
2005; Cheung & Spielman, 2002; Schadt et al. , 2003). One typical analysis of eQTL
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data is to identify the genetic variants that are associated with the expression level of a
particular gene. Such analyses have provided important insights about cis- and tranregulation of gene expressions (Bing & Hoeschele, 2005; Chen et al. , 2007; Jansen &
Nap, 2001).
Gaussian graphical models have been applied to infer the relationship between
genes at the transcriptional level (Li & Gui, 2006; Peng & Zhu, 2009; Schafer &
Strimmer, 2005; Segal et al. , 2005), where the precision matrix (inverse covariance
matrix) for multivariate normal data has an interpretation of conditional dependency
and graphical structure.

Compared with marginal dependency, conditional depen-

dency can capture the “direct” link between the variables. In gene expression data
analysis, the expression levels are treated as multivariate normal variables, whose
conditional dependency structure can be captured by the precision matrix. Since the
variation in the expression level for a given gene can usually be explained by a small
subset of other genes, the precision matrix for gene expression data is expected to be
sparse. For example, Figure 4.1 shows as MAPK signalling pathway from the KEGG
database, where the links between the genes are sparse.
Estimation of high-dimensional Gaussian graphical models has been an active area
of research in recent years. Meinshausen & Bühlmann (2006) proposed to identify
edges for each node in the graph by using `1 penalized regression to select the variables that are associated with this particular node. In this approach, the graphical
model estimation problem has been reduced to p separate high dimensional variable
selection problems. The links are selected without estimating the precision matrix.
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Variable selection methods and their properties have been discussed in Candès &
Tao (2007); Cai et al. (2010); James et al. (2009); Tibshirani (1996); Wainwright
(2009); Zou (2006) with Lasso or Dantzig selector, in Fan et al. (2009); Zhang (2010)
with non-concave SCAD or MCP penalties, and in Yuan & Lin (2006); Zou & Hastie
(2005) with group lasso or elastic net for regression problem with certain structures. Other methods to infer the precision matrix and the graphical structure is to
apply a penalized maximum likelihood approach, including Friedman et al. (2008);
Rothman et al. (2008); Yuan & Lin (2007). Friedman et al. (2008) proposed a fast
block coordinate descent algorithm, called glasso, to solve the penalized likelihood
maximization problem. Cai et al. (In press) proposed a constrained `1 minimization estimator (clime) for precision matrix estimation and obtained the results on
convergence rate and sign consistency.
Although direct application of the Gaussian graphical model to gene expression
data alone provides some insights about gene regulation at the expression level, it
does not fully utilize the available information. Gene expression data alone is unable
to fully capture the gene activities. The estimation can be improved by incorporating
other information such as genetic variants information from the typical genetical
genomic studies. Since some genetic variants have effects on expression levels of
multiple genes and therefore may serve as confounders while detecting the association
between the genes. Ignoring the effects of genetic variants on the gene expression levels
can lead to both false positives and false negatives for associations in the gene network
graph. In order to adjust for the effects of genetic variants on gene expressions, Yin
& Li (2011) proposed a sparse conditional Gaussian graphical model (cggm) for
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analysis of genetical genomics data. The model simultaneously identifies the genetic
variants associated with gene expressions and constructs sparse Gaussian graphical
model by maximizing a `1 penalized joint likelihood of the regression coefficients and
the precision matrix. However, the non-concavity of the objective function creates
difficulties to both theoretical analysis and computational implementation.
In this paper, we introduce a sparse multivariate high dimensional regression
model for studying the conditional independent relationships among a set of genes
adjusting for possible genetic effects. The model allows the mean of gene expression levels to depend on other variables such as genetic markers and therefore allows
different subjects to have different means. The model can be regarded as a covariateadjusted Gaussian graphical model. We consider the estimation of both coefficient
matrix and precision matrix and present a covariate adjusted precision matrix estimation (capme) method. capme is a two-stage method, where in each stage, we
use constrained `1 minimization approach to solve for coefficient matrix or precision
matrix. The two matrices are estimated separately. Algorithm-wise, capme can
be easily implemented by linear programming. An R package of capme has been
developed and is available on the CRAN (http://cran.r-project.org/). We provide the rates of convergence and the estimation bounds for the estimates of both
the regression coefficient matrix and the precision matrix. In addition, we propose
a simple threshold procedure on the estimated precision matrix in order to select
the covariate-adjusted Gaussian graphical structure. We obtain the consistency result on graph structure selection. The method is applied to a yeast eQTL data to
demonstrate the application of constructing gene regulatory network.
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The paper is organized as follows. We present the covariate-adjusted Gaussian
graphical model and capme in Section 4.2. In Section 4.3 and Section 4.4, we present
the asymptotical property of capme. Our method is further justified in Section 4.5,
where we conduct the numerical studies to compare the performances of capme and
other competitive methods such as clime, cggm and glasso. We use the yeast
eQTL data to demonstrate the application of our method. We conclude the paper
with a brief discussion in Section 4.7. The proofs are relegated to the Appendix.

4.2

Covariate Adjusted Precision Matrix Estimation

We first introduce the notation of matrix norms used in the rest of the paper. For
a vector a = (a1 , . . . , ap )T ∈ R, define |a|1 =

Pp
i=1

|ai | and |a|2 =

a matrix A = (aij ) ∈ Rp×q , we define the entrywise `1 norm |A|1 =

pPp
i=1

a2i . For

Pp Pq
i=1

j=1 |aij |

and the entrywise `∞ norm |A|∞ = max1≤i≤p,q≤j≤q |aij |. We further define the matrix `1 norm by kAkL1 = max1≤j≤q
max1≤i≤p

Pq

by kAkF =

j=1 |aij |,

qP
i,j

Pp

i=1 |aij |,

the matrix `∞ norm by kAkL∞ =

the spectral norm kAk2 = max|x|2 ≤1 |Ax|2 and the Frobenius norm

a2ij . The notation A Â 0 means that A is positive definite.

82

4.2.1

Covariate Adjusted Gaussian Graphical Model

We consider the following model

y = Γ0 x + z,

(4.2.1)

where y = (y1 , . . . , yp )T is a random vector denoting the expression levels for p genes,
x = (x1 , . . . , xq )T is a random vector describe the coding for q genetic markers, Γ0 is
a p×q unknown coefficient matrix, z is a p×1 normal random vector with mean zero,
covariance matrix Σ0 and precision matrix Ω0 = (ωij0 ) = Σ−1
0 . Since the segregating
population in the genetical genomics experiments can be viewed as random due to the
random recombination process, x can be treated as a random variable. We further
assume x and z are independent. Assume that we have n i.i.d observations (xk , y k )
(k = 1, . . . , n) for the model.
Model (4.2.1) is similar to the seemingly unrelated regression (sur) model in
Zeller (1962), which aimed to improve the estimation efficiency of the effects of genetic variants on gene expressions by considering the residual correlations of the gene
expressions of many genes. However, the model is viewed differently here with a focus
on improving the estimation accuracy of the conditional dependency structure of y
by adjusting for the covariates x.
In eQTL studies, each row of Γ0 is assumed to be sparse since one gene is expected
to have only a few genetic regulators. The precision matrix Ω0 is also expected to be
sparse, since typical genetic networks have limited links. Ω0 has an interpretation of
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conditional dependency and can be use to construct a conditional dependency graph.
To be specific, let G = (V, E) be a graph representing conditional independence
relations between components of y. The vertex set V has p components y1 , . . . , yp
and the edge set E consists of pairs (i, j), where (i, j) ∈ E if there is an edge between
yi and yj . The edge between yi and yj is excluded from E if and only if zi and
zj are independent given other zk (k 6= i, j). Since z follow a multivariate normal
distribution, the conditional independence of zi and zj leads to ωij = 0. We are
interested in detecting the non-zero entries of Ω0 so that we can construct a conditional
independency graph for y after the effects of the covariates x on y are adjusted. Such
a graphical model is called the covariate-adjusted Gaussian graphical model.
In this paper, we consider the setting where both p and q can be much larger than
n. The assumption fits the real application of analysis of genetical genomics data
where there are usually thousands of genes and genetic markers, but relatively small
sample sizes.

4.2.2

Estimation of Γ0

When q = 1, many novel methods have been developed for estimation of Γ0 ,
including the methods based on the `1 minimization such as the lasso in Tibshirani
(1996) and the Dantzig selector in Candès & Tao (2007). We propose to develop
method for estimating Γ0 using l1 minimization that can be treated as a multivariate
extension of the Dantzig selector.
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Let ȳ = n−1

Pn
k=1

y k , x̄ = n−1

Pn
k=1

xk , z̄ = n−1

Pn
k=1

z k . Then it follows that

y k − ȳ = Γ0 (xk − x̄) + z k − z̄.

Set Sxy = n−1

Pn

k=1 (y k

− ȳ)(xk − x̄)T and Sxx = n−1

(4.2.2)

Pn

k=1 (xk

− x̄)(xk − x̄)T . We

propose to estimate Γ by solving the following the optimization problem:
¯
¯
¯
¯
min|Γ|1 subj ¯Sxy − ΓSxx ¯

∞

≤ λn ,

1 ≤ i ≤ p, 1 ≤ j ≤ q,

(4.2.3)

where λn is a tuning parameter that will be specified later. Note that (4.2.3) is
equivalent to the following p optimization problems: for 1 ≤ i ≤ p,
¯
¯
¯
¯
min|γ i |1 subj ¯Sxy,i − γ T
S
¯
xx
i

∞

≤ λn ,

1 ≤ j ≤ q,

(4.2.4)

where Γ =: (γ 1 , . . . , γ p )T and Sxy =: (Sxy,1 , . . . , Sxy,p )T . This is exactly the Dantzig
selector formulation for simple regression analysis for the ith gene and its solution
can therefore be obtained by solving the corresponding linear programming problem
(Candès & Romberg, 2005) or by some alternative methods (Becker & Grant, 2010;
Lu, 2009; ?). This simple observation is useful for implementation and technical
analysis. In this paper and the R package capme we develop, we implement a linear
programming optimization using the primal dual and interior point algorithm.
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4.2.3

Estimation of Ω0

Suppose now we have an estimation Γ̂ by (4.2.3). After plugging Γ̂ into the
equations (4.2.2), Ω0 can be estimated by the method of constrained `1 -minimization
proposed in Cai et al. (In press). Let
n

Syy

1X
=
(y k − Γ̂xk )(y k − Γ̂xk )T .
n k=1

We estimate Ω0 by solving the optimization problem:

min|Ω|1 subj |Ip×p − Syy Ω|∞ ≤ τn ,

(4.2.5)

where τn is a tuning parameter. Let Ω̂1 = (ω̂ij1 ) be any solution of (4.2.5). This
constrained l1 minimization approach is the same as the clime proposed in Cai et al.
(In press), except that Syy depend on the estimated regression coefficient matrix
Γ̂. Note that we do not impose the symmetry condition on Ω̂1 and as a result the
solution is not symmetric in general. The final capme estimator of Ω0 , denoted by
Ω̂ = (ω̂ij ), is obtained by symmetrizing the estimator as follows.

1
1
1
Ω̂ = (ω̂ij ), where ω̂ij = ω̂ji = ω̂ij1 I{|ω̂ij1 | ≤ |ω̂ji
|} + ω̂ji
I{|ω̂ij1 | > |ω̂ji
|}.

(4.2.6)

As in (4.2.4), the problem (4.2.6) can be decomposed into p optimization problems.
For 1 ≤ i ≤ p, let ω̂ i be the solution of the following convex optimization problem

min|ω i |1 subject to |ei − Syy ω i |∞ ≤ τn ,
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(4.2.7)

where ω i is a vector in Rp , ei is a standard unit vector in Rp with 1 in the i-th
coordinate and 0 in all other coordinates.

4.3

Rates of Convergence of the Estimators

In this section, we study the theoretical properties of the estimators Γ̂ and Ω̂.
Write x = (x1 , . . . , xq )T , z = (z1 , . . . , zp )T and u = z T Ω0 = (u1 , . . . , up ). We need
the following conditions to establish the rates of convergence.
A1. Let log(p ∨ q) = o(n). Suppose that there exists some η > 0 and K > 0 such
that

E exp(tx2i ) ≤ K,

E exp(tzj2 ) ≤ K,

0
E exp(tu2j /ωjj
)≤K

for all t ≤ η, 1 ≤ i ≤ q and 1 ≤ j ≤ p.
A2. The regression coefficient matrix Γ0 belongs to the following class with 0 ≤ δ1 <
1:
n

p×q

Vδ1 := Vδ1 (s1 (q)) = Γ ∈ R

: kΓkL∞ ≤ Vq ,

q
o
X
max
|γij |δ1 ≤ s1 (q) .

1≤i≤p

j=1

A3. The precision matrix Ω0 = (ωij0 )p×q belongs to the following class with 0 ≤ δ2 <
1:
n
Uδ2 := Uδ2 (s2 (p)) =

Ω Â 0 : kΩkL∞ ≤ Mp ,
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p
X
max
|ωij |δ2 ≤ s2 (p)

1≤i≤p

j=1

o
λmax (Ω)/λmin (Ω) ≤ C0 .

A4. There exists some Nq > 0 such that the matrix l∞ norm of Σ−1
X satisfies

kΣ−1
X k L ∞ ≤ Nq ,

where ΣX = cov(X).
Condition A1 is a sub-gaussian condition on x, z and z T Ω0 . Note that the
0
variance of uj is ωjj
. The dimensions p and q can be of the order of exp(o(n)).

Conditions A2 and A3 assume the uniformity class of matrices for the regression
coefficient matrix and the precision matrix. Similar parameter spaces have also been
used in Bickel and Levina (2008) and Cai et al. (2011). Note that V0 and U0 are
classes of matrices with the sparsity s1 (q) and s2 (p) sparse, respectively. A2 and A3
also bound the matrix L∞ norm of Γ0 and Ω0 . Finally, Condition A4 bounds the
matrix L∞ norm of the inverse covariance matrix of X.

4.3.1

Convergence rates of Γ̂ − Γ0

The estimation error Γ̂ − Γ0 can be measured by three types of matrix norms:
the matrix L∞ norm, the Frobenius norm and the entry-wise l∞ norm. The matrix
L∞ norm measures the accuracy of the estimation of Γ0 . The Frobenius is also an
reasonable measure on the accuracy of the estimation of Γ0 because Γ0 could be an
asymmetric regression coefficient matrix. The entry-wise l∞ norm can be used to
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recover the support of Γ0 by a further thresholding step. We have the following rate
of convergence of the estimator Γ̂.
Theorem 4.3.1. Suppose (A1), (A2) and (A4) hold. Let Γ0 ∈ Vδ1 and λn =
C1

p

(log(pq))/n, where C1 > 0 is a sufficiently large constant. Then with probability

greater than 1 − O((pq)−1 ), we have
³ log(pq) ´(1−δ1 )/2
kΓ̂ − Γ0 kL∞ ≤ C(Vq Nq )1−δ1 s1 (q)
n

(4.3.1)

³ log(pq) ´1−δ1 /2
1
2
2−δ1
kΓ̂ − Γ0 kF ≤ C(Vq Nq )
s1 (q)
p
n

(4.3.2)

and

for some constant C > 0.

Theorem 1 shows that the regression coefficients matrix Γ0 can be estimated consistently under the Frobenius norm if the sparsity s1 (q) of Γ0 is of the order of
³
³
´1−δ1 /2 ´
n
o (Vq Nq )δ1 −2 log(pq)
. The requirement on the dimension p and q is mild.
To see this, if s1 (q) = O(nr1 ) for some r1 < 1 − δ1 /2 and Vq Nq is bounded, then p
and q can be as large as exp(nr2 ) for some r2 < 1 − δ1 /2 − r1 .
Theorem 4.3.2. Suppose the conditions in Theorem 4.3.1 hold. Then with probability
greater than 1 − O((pq)−1 ), we have

|Γ̂ − Γ0 |∞ ≤ C0 Vq Nq
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³ log(pq) ´1/2
n

(4.3.3)

for some constant C0 > 0.

The rate under the element-wise l∞ norm is critical to the support recovery. Define
Γ̃thr = (γ̃ij ) with
γ̃ij = γ̂ij I{|γ̂ij | ≥ C0 Vq Nq

³ log(pq) ´1/2
n

},

where (γ̂ij ) := Γ̂. Let S(Γ0 ) = {(i, j) : γij0 6= 0} and γmin = min(i,j)∈S(Γ0 ) |γij |.
Theorem 4.3.3. Suppose the conditions in Theorem 4.3.1 hold and

γmin ≥ 2C0 Vq Nq

³ log(pq) ´1/2
n

.

(4.3.4)

Then with probability greater than 1 − O((pq)−1 ), we have S(Γ̃thr ) = S(Γ0 ).

The lower bound condition (4.3.4) puts requirements on the non-zero entries whose
magnitude cannot be too small for support recovery.

4.3.2

Convergence rates of Ω̂ − Ω0

In this section, we consider the rate of Ω̂ − Ω0 under the spectral norm kAk2 =
max|x|=1 |Ax|2 and the element-wise l∞ norm. The rate under the spectral norm is
important because it can lead to the consistency of the estimation of eigenvalues and
eigenvectors, which is critical in the principal component analysis. The rate under
the spectral norm also is essentially needed in developing theoretical properties for
various statistical inference problems when the estimator of precision matrix is used.
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Theorem 4.3.4. Suppose (A1) and (A3) hold. Let Γ0 ∈ Vδ1 , Ω0 ∈ Uδ2 and

s1 (q) ≤

CMp−1 (Vq Nq )−1+δ1

Let τn = C2

n³
min

o
n ´(1−δ1 )/2 ³ n ´1−δ1 /2
−1
,
(Vq Nq )
(4.3.5)
.
log(pq)
log(pq)

p
(log(pq))/n, where C2 > 0 is a sufficiently large constant. Then with

probability greater than 1 − O((pq)−1 ), we have
³ log(pq) ´(1−δ2 )/2
kΩ̂ − Ω0 k2 ≤ CMp1−δ2 s2 (p)
n

(4.3.6)

for some constant C > 0.

The condition (4.3.5) on the sparsity s1 (q) of Γ0 ensures that Γ0 can be well estimated with certain rate so that y − Γ̂0 x can be used to replace the oracle one y −Γ0 x.
The convergence rate in (4.3.6) is optimal. In fact, if Γ0 = 0 or is known in advance,
³
´
the minimax optimal rate of estimation of Ω0 is O Mp1−δ2 s2 (p)(log p/n)(1−δ2 )/2 (Cai
et al. , In press). If q = O(p), then the rate in (4.3.6) is the same as the oracle optimal
rate and thus is also optimal.
The next theorem shows the convergence rate under the element-wise l∞ norm,
which is useful for the support recovery for the precision matrix Ω.
Theorem 4.3.5. Under the conditions of Theorem 4.3.4, we have with probability
greater than 1 − O((pq)−1 ),

|Ω̂ − Ω0 |∞ ≤ CMp

³ log(pq) ´1/2
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n

,

(4.3.7)

where C > 0 is a constant.

As shown in Cai et al. (2011), the minimax optimal rate under element-wise l∞
³
´
1/2
norm of estimation of precision matrix is O Mp (log p/n)
. Hence CAPME can
achieve the same optimal rate as the case that Γ0 is known.

4.4

Graphical Model Selection Consistency

The support recovery of Ω0 is closely related to graphical model selection. When
Γ0 = 0, the problem is reduced to the Gaussian graphical model selection and has
been the subject of research in many recent papers. Suppose that Ω0 belongs to U0 .
We are interested in estimating the support of Ω0 , S(Ω0 ) = {(i, j) : ωij0 6= 0} when
Γ0 6= 0. However, the estimator Ω̂ from the capme may not be sparse. Using the
rate under the element-wise norm given in Theorem 4.3.5, we can further threshold
the entries in Ω̂ and obtain a sparse estimator of the precision matrix. Let

Ω̂r = (ω̂ijr ),

0

where ω̂ijr = ω̂ij I{|ω̂ij | ≥ τn },

0

where τn is a tuning parameter which will be specified later. Define θmin = min(i,j)∈S(Ω0 ) |ωij0 |,
and Ψ = {sign(ωij0 ) : 1 ≤ i, j ≤ p} and Ψ̂ = {sign(ω̂ijr ) : 1 ≤ i, j ≤ p} be the vector
of the signs of the elements of the true and the estimated precision matrix, where
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sign(t) is defined as





1
if t > 0




sign(t) =
0
if t = 0






 −1 if t < 0.

We have the following theorem on sign consistency of the estimator Ψ̂, i.e., the
estimator not only recovers the sparsity pattern of Γ0 , but also recovers the signs
of the nonzero elements.
0

0

Theorem 4.4.1. Let τn = 4Mp τn . Suppose that θmin > 2τn . Then under the conditions of Theorem 4.3.4, as n and p tending to infinity, we have with probability
tending to one, Ψ̂ = Ψ.

Theorem 4.4.1 shows that the support of Ω0 can be recovered exactly if the minimum of the nonzero entries in Ω0 has a lower bound which is not too small. The lower
bound condition is necessary in order to recovery the support exactly. In fact, sup0

pose that Γ0 = 0 or is known in advance. If θmin ≤ cτn for some small enough number
c > 0, then for any estimator of Ω0 , we are unable to recovery the support exactly
uniformly over the class of s2 (p) sparse precision matrices; see Cai et al. (2011).

4.5

Simulation results

We conduct simulation studies to evaluate the proposed procedure and to compare
it with several other procedures for precision matrix estimation. We consider four
different settings of p, q and n as presented in Table 4.1
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Table 4.1: Models and parameters used in simulations.
Model
Model
Model
Model
Model

1
2
3
4

parameters
p = 30, q = 15 and n = 100
p = 60, q = 30 and n = 100
p = 200, q = 100 and n = 120
p = 60, q = 30 and n = 100, with Γ = 0.

For each model, we first generate a p × q sparse coefficient matrix Γ and a p × p
sparse precision matrix Ω randomly. For Model 1-3, we set the average nonzero
proportion of each row of Γ to be 15/q. Therefore, for each Yj , there are in average
15 covariates contributed to its mean. And for all the models, we set the average
nonzero proportion of each row of Ω to be 5/q. This is to constrain the number of the
neighbors of each Yj in the graph. On average, there are 5 neighbors for each gene
nodes. We consider such setting since in genomic studies, it is reasonable to assume
that the number of genetic loci or SNPs that affect the expression level of a certain
gene is predetermined by the biological nature, as well as the gene pathway network.
As more and more genetic variables are included in the model, the coefficient and
the precision matrix will become more and more sparse. In order to make sure the
numerical stability, we adjust the diagonal level of the matrix so that the condition
number, defined as the ratio of the maximal and minimal singular values, is equal to
the dimension of the matrix p.
Model 1 has a relatively small (p + q)/n ratio. We consider this model to mimic
the application in elucidating small-scale gene regulatory pathways or constructing
of networks in other areas such as in social sciences. In addition, we set the coefficient matrix Γ is non-zero everywhere, representing the ’extreme’ case, in which
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the comparison between several methods can reveal more information. Model 2 has
a moderate (p + q)/n ratio, while Model 3 has a large (p + q)/n ratio, simulating
the situation in most genomic application. Model 4, on the other hand, simulates
the other ’extreme’ case, where we assume the coefficient matrix Γ is zero. Methods
not adjusting for covariates, like glasso or clime, assumes Γ equals to zero; while
capme conducts an additional step to estimate Γ.
For numerical experiments, we first generate random matrix according to the
settings of Models 1-4. For each replication of the simulations, we generate a q × n
covariate matrix X with each entry following a standard normal distribution and
the random error z following multivariate normal distribution with zero mean and
the covariance matrix Σ = Ω−1 . Following the model y = Γx + z, we generate the
outcome matrix y.
We compare the performances of capme with its competitors, including clime,
cggm and glasso. We use 5−fold cross validation to choose the tuning parameters
based on maximizing the cross-validated log-likelihood function

log det(Ω) − tr(Syy Ω).

We evaluate and compare the performances of the methods using several different criteria. The estimation error is evaluated in terms of operator norm, Frobenius
norm and l1 norm and the variable selection property is evaluated by Hamming distance (dist), specificity (spe), sensitivity (sen) and Matthews correlation coefficient
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(mcc), which are defined as the following:

tn
,
tn + fp
tp × tn − fp × fn

dist(Ω0 , Ω̂) = fn + fp,
mcc = p

spe =

sen =

(tp + fp)(tp + fn)(tn + fp)(tn + fn)

tp
,
tp + fn

.

Here, tp, tn, fp, fn are the numbers of true positives, true negatives, false positives
and false negatives. Here, ”positives” stands for non-zero entries in the estimators.
The performances over 50 replications are reported in Table 4.5 and Table 4.3.
In general, when the regression coefficient matrix for the means is dense, approaches that adjust for covariates work significantly better. For example, in Model
1, the coefficient matrix is non-zero everywhere, clime and glasso fail to produce
a sparse network, and the estimation errors are large when compared to capme and
cggm. Both capme and cggm perform almost equally well, while cggm outperforms
a little bit in estimation and capme works better in variable selection.
In Model 2, when the coefficient matrix is moderately sparse and (p + q)/n ratio
is moderate, clime and glasso performs worse than capme. cggm has reasonable
performance in variable selection, but its estimation error is relatively large. When
the (p + q)/n ratio becomes larger as in Model 3, cggm and glasso perform poorly.
capme outperforms all the competitors in both estimation error and variable selection.
In Model 4, the coefficient matrix Γ is set to be zero. The extra step capme
takes to estimate Γ does not affect its numerical performance. It has comparable
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performance to the methods glasso and clime assuming Γ is zero.
In general, capme has better performance especially in the relatively high dimensional setting. To further gain insight into how covariates can affect the estimation
of the precision matrix, Table 4.4 shows the extra false links that are identified by
glasso or clime as compared to capme or cggm and how many of these links that
can be due to shared genetic variants or confounders. clime and glasso identified
many false links due to the fact that shared confounders are not adjusted. capme detected a large proportion of the confounders and therefore successfully avoided many
false discoveries. In contrast, cggm identified a small set of confounders.
Table 4.2: Simulation results: estimation errors of four different methods for the
precision matrix as measured by different matrix norms based on 100 replications.
Numbers in parantheses are the simulation standard errors.
Model
Method Operator norm Frobenius norm Matrix l1 norm
capme 5.97(0.59)
15(0.73)
14.39(1.48)
clime
104.40(14.64)
64.42(2.51)
63(16.04)
cggm
4.84(0.80)
13.86(0.32)
10.6(1.05)
Model 1 glasso 7.68(0.05)
19.27(0.21)
16.45(0.39)
capme 7.93(0.1)
25.13(0.09)
16.3(0.16)
clime
8.01(0.15)
25.73(0.09)
16.45(0.29)
cggm
10.82(3.67)
23.86(0.55)
17.78(2.24)
Model 2 glasso 8.56(0.07)
27.65(0.32)
17.87(0.28)
capme 0.47(0)
12.02(0.01)
1.06(0.01)
clime
2.13(0.23)
19.29(0.5)
3.41(0.36)
cggm
9.54(0.01)
50.42(0.09)
20.33(0.08)
Model 3 glasso 9.54(0.01)
50.39(0.07)
20.32(0.08)
capme 5.14(0.22)
20.43(0.28)
12.12(0.81)
clime
7.69(0.12)
24.55(0.19)
14.36(0.5)
cggm
6.13(2.43)
21.38(0.28)
13.11(1.67)
Model 4 glasso 4.68(0.36)
21.88(0.27)
12.53(0.91)
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4.6

Real Data Analysis

We illustrate capme using the yeast eQTL data set generated by Brem and Krglyak (2005). The data set contains 112 yeast segregants grown from a cross involving
BY4716 and wild wild isolate RM11-1a. RNA was isolated and cDNA was hybridized
to microarrays with 6,216 yeast genes assayed on each array. Each of the 112 segregants were individually genotyped at 2,956 marker positions. Since many of the
markers are in high linkage disequilibrium, we chose 179 markers so that their pairwise correlations will not exceed 0.6.
In order to demonstrate the performance of capme and other methods, we focused
our analysis on 54 genes that belong to the yeast MAPK signaling pathway provided
by the KEGG database (Kanehisa et al., 2010). Figure 4.1 shows the MAPK signaling
pathway provided by the KEGG website, showing how yeast cells respond to different
cellular signals. Note that this pathway plot is not a graph since some gene nodes such
as Ste20, Ste11 and Ste7 appear in multiple locations. The corresponding undirected
graph as given in the Bioconductor database is shown in Figure 4.2(a), where the
nodes with the same color are involved in the same perturbation process and appeared
to be clustered in Figure 4.2(a). In this undirected graph, the salmon nodes are for
cell responses to the pheromone – mating process, the blue ones are for cell responses
to hypotonic shock – cell wall remodeling, the green ones are for cell responses to
high osmolarity – osmolyte synthesis and the yellow nodes are for cell responses
to starvation – filamentation. The hot pink nodes are those involved in multiple
perturbation processes.
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Table 4.3: Simulation results: variable selection performances as measured by distance
(dist), sensitivity (sen), specificity (spe) and the Matthew’s correlation (mcc), for
four different procedures, based on 100 replications. Numbers in parantheses are the
simulation standard errors.
Model
Method dist
spe
sen
mcc
capme 212.52(25.87)
0.99(0.02) 0.27(0.12) 0.41(0.09)
clime
616(2.91)
0(0)
1(0.01)
N aN (N A)
cggm
206.02(14.11)
0.9(0.03) 0.43(0.07) 0.38(0.05)
Model 1 glasso 561.7(15.24)
0.15(0.02) 0.85(0.03) 0(0.05)
capme 616.04(15.97)
0.96(0.01) 0.2(0.02) 0.23(0.02)
clime
852.44(105.51) 0.88(0.04) 0.2(0.04) 0.09(0.03)
cggm
678.68(120.12) 0.92(0.05) 0.2(0.06) 0.15(0.05)
Model 2 glasso 2125.98(77.58) 0.35(0.03) 0.64(0.05) 0(0.02)
capme 2334.48(164.55) 0.99(0)
0.11(0.01) 0.19(0.02)
clime
2831.48(163.86) 0.98(0)
0.13(0.01) 0.15(0.01)
cggm
9273.68(703.07) 0.8(0.02) 0.22(0.03) 0.01(0.01)
Model 3 glasso 8878.04(528.67) 0.81(0.01) 0.21(0.02) 0.01(0.01)
capme 472.88(22.25)
0.92(0.01) 0.59(0.03) 0.52(0.02)
clime
461.68(27.33)
0.95(0.02) 0.47(0.06) 0.49(0.03)
cggm
631.94(46.66)
0.88(0.02) 0.52(0.04) 0.37(0.02)
Model 4 glasso 872.82(82.49)
0.77(0.04) 0.65(0.05) 0.34(0.02)

Figure 4.1: The yeast MAPK signaling pathway from the KEGG database, illustrating the signaling paths in responses to different signals. Note that some genes appear
in multiple paths. http://www.genome.jp/kegg/pathway/sce/sce04011.html
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Table 4.4: Simulation results: effects of genetic variants on Gaussian graph recovery.
For each model, when two methods are compared, the column labeled as “FD” shows
the number of wrong links that are identified using the Gaussian graphical model
(glasso and clime) but not by the covariance adjusted Gaussian graphical model
(cggm and capme); the column labeled as “Covariate (true)” shows that among the
wrong links under the FD, the number of pairs of genes that share at least on genetic
variants based on the true model; the column labeled as “Covariate (estimated)”
shows that among the wrong links under the FD, the number of pairs of genes that
share at least on genetic variants based on the estimated covariate adjusted Gaussian
graphical model.
Model

Methods
FD
glasso/capme 258.31 (8.02)
glasso/cggm
166.93 (126.63)
clime/capme
303.78 (5.22)
Model 1 clime/cggm
196.86 (149.15)
glasso/capme 910.91 (49.08)
glasso/cggm
946.77 (145.39)
clime/capme
166.04 (58.85)
Model 2 clime/cggm
178.10 (67.52)
glasso/capme 3597.16 (283.49)
glasso/cggm
516.65 (124.48)
clime/capme
349.52 (77.90)
Model 3 clime/cggm
326.94 (58.70)
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Covariate(true) Covariate(estimated)
258.31 (8.02)
258.31 (8.02)
166.93 (126.63) 166.93 (126.63)
303.78 (5.22)
303.78 (5.22)
196.86 (149.15) 196.86 (149.15)
910.91 (49.08)
910.91 (49.08)
946.77 (145.39) 923.01 (163.46)
166.04 (58.85)
166.04 (58.85)
178.10 (67.52)
173.36 (67.22)
3423.1 (261.98) 2454.5 (355.33)
478.39 (116.65) 0 (0)
311.80 (70.28)
237.24 (82.62)
282.22 (51.39)
0 (0)
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Figure 4.2: (a) The undirected graph of the yeast MAPK signaling pathway; (b)
The graph estimated by the capme; (c) The graph estimated by the clime. (d) The
graph estimated from the glasso. Different colors correspond to different signalling
pathways that the cells respond to different signals.
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We applied capme to this set of 54 genes and 179 markers and used 5-fold cross
validation to choose the tuning parameters. The cross validation chose λ = 0.15
and τ = 0.19, which lead to capme to select 138 non-zero entries for the precision
matrix and 42 links among the 54 genes. In addition, capme identified 181 non-zero
entries for the coefficient matrix, indicating many gene expression levels are affected
by genetic variants. The number of genetic markers that are associated with a given
gene ranges from 0 to 29, with a mean value of 3.35. There are 54 pairs of genes
sharing at least one common genetic variant. If we do not adjust for the genetic
effects on gene expressions, shared genetic variants can lead to false links between
the gene pairs. Figure 4.2(b) shows the graph constructed by capme based on the
precision matrix estimator. It is very interesting to see that the nodes of the same
color tend to linked together based on the conditional Gaussian graph identified by
capme, indicating that the data and our model can indeed recover some important
links related to the MAPK signaling pathway. For example, the kinase Sho1 is linked
to its downstream gene MCM1 and the upper part of the pheromone – mating process
is captured well in the estimated graph.
As a comparison, we applied clime and glasso to the gene expressions of 54 genes
without adjusting for the genetic marker effect on gene expressions. We used the 5fold cross-validation to choose the tuning parameters for both methods, resulting
λclime = 0.25 and λglasso = 0.007. clime identified 200 non-zero entries for the
precision matrix and therefore 73 links of 54 genes, while glasso identified 1186
non-zero entries and therefore 566 links. The corresponding graphs are presented in
Figure 4.2(c) and Figure 4.2(d), where the genes involved in different perturbation
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processes are mixed together. The results obtained from clime and glasso are less
systematic when compared to the results of capme. There are too many false links so
that the biologically meaningful links cannot be distinguished. One potential reason
that clime and glasso failed to cluster the genes well is that they do not adjust for
genetic variants associated with the expression levels.
We noticed that some links presented in the original pathway graph Figure 4.2(a)
are missed by the graph derived from the estimated precision matrix. One reason is
that many of the links of the MAPK pathway can only be observed at the protein
levels but not at the gene expression levels. Another reason is that the cellular systems
might not be perturbed enough to provide enough information to infer these links.
Figure 4.3(a) shows the histogram of the correlations of genes that are linked based
on the MAPK signaling pathway, where some of the linked gene pairs have very small
marginal correlations. capme and clime are not able to recover the links. On the
other hand, the linked genes identified by these two methods tend to have higher
marginal correlations (Figure 4.3(b) and Figure 4.3(c)). In contrast, some linked
genes identified by glasso have small marginal correlations in their expression levels
(Figure 4.3(d)).

4.7

Conclusion and Discussion

We have presented a sparse high dimensional multivariate regression model for
estimating the gene network based on the genetical genomics data in order to account
for genetic effects on gene expressions. By including the genetic information in the
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Figure 4.3: Analysis of yeast eQTL data set: histograms of marginal correlations
for pairs of linked genes on the MAPK signaling pathway (a), and the linked genes
identified by capme (b), clime (c) and glasso (d).
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model, the variations and the dependency of gene expression levels are separated into
two parts: the correlation due to common genetic factors and the coherence for gene
transcriptional activities. In the multivariate regression model, we used the coefficient
matrix to model the first part and the precision matrix to model the second part. The
numerical experiments demonstrated that our proposed method capme can capture
the network more accurately than its competitors such as clime and glasso. We
applied several methods to the analysis of the yeast eQTL data and observed that
the standard Gaussian graphical model resulted in too many false links and fail to
provide any biological insights of the data. In contrast, capme provides a sparser and
more interpretable graph. Due to the limited capacity of gene expression data, one
should not expect that the gene regulatory network can be accurately recovered by
gene expression data alone. However, as we have demonstrated, the joint modeling
of genetic markers and gene expressions, together with the proposed method capme,
can indeed provide important information about the gene networks.
In this paper, we focused on estimating the sparse precision matrix for the gene
expression data accounting for the genetics effects. We estimate the coefficient matrix
without utilizing the dependency information of the gene expressions, which may lead
to some loss of efficiency. In other applications, the focus can be on the inference of
the regression coefficients of multiple regressions. It is interesting to study whether
one can gain efficiency in estimating the regression coefficients when the estimated
sparse precision matrix is utilized. In the low dimensional setting, such problem is
considered by sur model (Zeller, 1962).

105

4.8

Appendix - Proofs of the Theorems

The first lemma is an exponential inequality on the partial sums of independent
random variables Cai & Liu (In press).
Lemma 4.8.1. Let ξ1 , · · · , ξn be independent random variables with mean zero. Suppose that there exists some t > 0 and B̄n such that
n
X

Eξk2 et|ξk | ≤ B̄n2 .

k=1

Then for 0 < x ≤ B̄n ,
n
´
³X
ξk ≥ Ct B̄n x ≤ exp(−x2 ),
P

(4.8.1)

k=1

where Ct = t + t−1 .

Proof of Theorems 4.3.1 and 4.3.2. Without loss of generality, we assume that
√
Ex = 0. We show that with probability greater than 1 − O({ log pq(pq)a }−1 ),
¯
¯
¯
¯
S
−
Γ
S
¯ xy
0 xx ¯

∞

≤ λn .

(4.8.2)

To prove (4.8.2), it suffices to show that
n
¯1 X
¯
¯
T¯
(z k − z̄)(xk − x̄) ¯ ≤ λn .
¯
n k=1
∞

(4.8.3)

Taking ξk = zki xkj in Lemma 4.8.1 and note that maxi,j E exp(t|zki xkj |) ≤ K for all
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|t| ≤ η, we have
r
n
¯X
¯
³
´
¯
−1 ¯
max P n ¯
zki xkj ¯ ≥ λn /2 ≤ C
i,j

k=1

1
(pq)−2−2a .
log pq

(4.8.4)

By Lemma 4.8.1, we have
³
´
p
max P |x̄j | ≥ CM log q/n ≤ Cq −M
j

and
³
´
p
max P |z̄i | ≥ CM log p/n ≤ Cp−M
i

for some bounded constant CM . This implies (4.8.3). Let Γ̂ =: (γ̂ij ) = (γ̂1T , . . . , γ̂pT )T
be the solution of (4.2.3). Then by (4.8.2), we have
¯
¯
¯
¯
¯(Γ̂ − Γ0 )Sxx ¯ ≤ 2λn .

Moreover, by the equivalence between (4.2.3) and (4.2.4), we have
Pq

0
j=1 |γij |

for all 1 ≤ i ≤ p. Set kΓ0 kL∞ = max1≤i≤p

Pq

0
j=1 |γij |.

Pq

j=1 |γ̂ij |

≤

We have kΓ̂kL∞ ≤

kΓ0 kL∞ . Also by Lemma 4.8.1, we have
¯
³¯
¯
¯
P ¯Σx − Sxx ¯

∞

≥ Cτ

p

´
log q/n ≤ q −τ

√
for any τ > 0. Then, with probability greater than 1 − O({ log pq(pq)a }−1 ) − q −τ ,
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we have

|(Γ̂ − Γ0 )Σx |∞ ≤ |(Γ̂ − Γ0 )Sxx |∞ + |(Γ̂ − Γ0 )(Σx − Sxx )|∞
≤ 2λn + 2Cτ kΓ0 kL∞

p
log q/n.

It follows that

|Γ̂ − Γ0 |∞ ≤ |(Γ̂ − Γ0 )Σx |∞ kΣ−1
x k L1
−1
≤ 2kΣ−1
x kL1 λn + Cτ kΣx kL1 kΓ0 kL∞

p

log q/n,

which proves (4.3.3).
Let tn = |Γ̂ − Γ0 |∞ . Define

hj = (hj1 , . . . , hjq ) = γ̂j − γj0 ;
h1j = (γ̂ji I{|γ̂ji | ≥ 2tn } : 1 ≤ i ≤ q} − γj0 ;
h2j = hj − h1j .

Then

|h2j |1 − |h1j |1 + |γj0 |1 ≤ |h2j |1 + |h1j + γj0 |1 = |hj + γj0 |1 ≤ |γj0 |1 .

So we have |hj |1 ≤ 2|h1j |1 . It suffices to estimate |h1j |1 . We have

|h1j |1

q
X
0
=
|γ̂ji I{|γ̂ji | ≥ 2tn } − γji
|
i=1
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(4.8.5)

q
q
X
X
0
0
=
|γ̂ji − γji |I{|γ̂ji | ≥ 2tn } +
|γji
|I{|γ̂ji | < 2tn }
i=1

≤

q
X

i=1

q
X
0
0
0
tn I{|γji | ≥ tn } +
|γji
|I{|γji
| < 3tn }

i=1

≤

1
t1−δ
n

q
X

i=1
0 δ1
|γji
|

1−δ1

+ (3tn )

i=1

q
X
0 δ1
|γji
| .
i=1

Note that
1
kΓ̂ − Γk2F ≤ kΓ̂ − Γk1 |Γ̂ − Γ|∞ ,
p
√
(4.3.1) and (4.3.2) hold with probability greater than 1 − O({ log pq(pq)a }−1 ) −
q −τ .

Proof of Theorems 4.3.4 and 4.3.5. Set
n

1X
(z k − z̄)(z k − z̄)T .
Σ̂z =
n k=1
We suppose that

|(Sxx − Σ̂z )Ω0 |∞ ≤ τn

(4.8.6)

|(Σ̂z − Σ0 )Ω0 |∞ ≤ τn .

(4.8.7)

and
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Then we have

|I − Sxx Ω0 |∞ = |(Sxx − Σ0 )Ω0 |∞ ≤ 2τn .

It follows that

|Ω̂1 − Ω0 |∞ ≤ |(I − Ω0 Sxx )Ω̂1 |∞ + |Ω0 (I − Sxx Ω̂1 )|∞ ≤ 2kΩ0 kL1 τn .

This proves Theorem 4.3.5. Following the arguments as the proof of Theorem 1, we
can get Theorem 4.3.4.
It remains to prove (4.8.6) and (4.8.7). Write ∆n = Γ̂ − Γ0 . Then we have
n

Sxx =

1X
(z k − ∆n xk )(z k − ∆n xk )T .
n k=1

We now prove that with probability greater than 1 − O((pq)−a ),
r
n
¯
¯1 X
log max(p, q)
¯
T T¯
−1
z k z k ∆n ¯ ≤ CMp
¯
n k=1
n
∞

(4.8.8)

r
n
¯1 X
¯
log max(p, q)
¯
¯
.
∆n xk xTk ∆Tn ¯ ≤ CMp−1
¯
n k=1
n
∞

(4.8.9)

and
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First, recall that
n
¯X
¯
³
´
¯
−1 ¯
max P n ¯
zki xkj ¯ ≥ λn /2 ≤ C(pq)−2−2a .
i,j

(4.8.10)

k=1

Write ∆n = (δij ). To prove (4.8.8), we only need to show that with probability greater
than 1 − O((pq)−a ),
r
n
¯1 X
¯
log max(p, q)
¯
¯
max ¯
(zik xi1 δl1 + · · · + zik xiq δlq )¯ ≤ C
.
k,l
n i=1
n
By (4.3.1), (4.3.5) and (4.8.10),
n X
n
n
¯1 X
¯
¯1 X
¯
¯
¯
¯
¯
max ¯
zik xij δlj ¯ ≤ kΓ̂ − Γ0 kl∞ max ¯
zik xij ¯
k,l
k,l,j n
n i=1 j=1
i=1
n
¯1 X
¯
¯
¯
≤ CMp−1 max ¯
zik xij ¯
k,l,j n
i=1
p
≤ CMp−1 log max(p, q)/n.

(4.8.11)

Thus (4.8.8) holds. It remains to show (4.8.9), which is equivalent to show that with
probability greater than 1 − O((pq)−a ),
r
q
q
n X
¯
¯1 X
X
log max(p, q)
¯
¯
max ¯
δkj xij
δlj xij ¯ ≤ CMp−1
.
k,l
n i=1 j=1
n
j=1
By Lemma 4.8.1, we can get
n
³1 X
´
max P
x2ij ≥ Cη,K = O((pq)−M )
j
n i=1
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(4.8.12)

for any M > 0. By (4.3.3), (4.3.1) and (4.3.5),
q
q
n
n
´2
X
X
1 X³X
2 1
max
δkj xij ≤ max
δkj
x2ij ≤ CMp−1
k
k
n i=1 j=1
n i=1
j=1

r

log max(p, q)
n

with probability greater than 1 − O((pq)−a ). This implies (4.8.12).
We next prove (4.8.7). Write
n

1X
(Σ̂z − Σ0 )Ω0 =
z k z Tk Ω0 − z̄z̄ T Ω0 .
n k=1
0
0
Note that var(zki ) = σii0 and var((z Tk Ω0 )j ) = ωjj
. By A2, maxi σii0 maxj ωjj
≤ C0 . By

Lemma 1, we have
n
¯
³¯ 1 X
¯
¯
max P ¯
zki (z Tk Ω0 )j ¯ ≥ C
i,j
n k=1

r

(2 + a) log p ´
≤ Cp−a−2
n

and
³
max P |(z̄ T Ω0 )j | ≥ C
j

s

0
(2 + a)ωjj
log p ´
≤ Cp−a−2
n

for some bounded constant C depending only on C0 , η and K. This yields (4.8.7).
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Chapter 5
Future Research
Our work of single tissue eQTL experiments can be extended to the multi-tissue
eQTL experiments. It has been well established that gene expression levels are tissue
specific in both model organisms and in human. So are the interaction relationship
between the genes. One gene might only regulate another gene in some specific tissues
involved with certain functions. However, since a lot of genes are involved in the vital
or basic activities of tissues, the transcription actives among different tissues should
be similar. In other words, the gene regulatory networks are similar across different
tissues except for some small differences.
Such pattern can be reflected by the correlations between gene expressions in
different tissues. As an illustration, we obtain tissue-specific gene expression data from
the the the Atlas of Gene Expression in Mouse Aging Project (AGEMAP) (Zahn et al.
, 2007). For each pair of genes, their marginal correlation is calculated seven tissues
(thymus, hippocampus, spleen, spinal cord, adrenal and lung) and plotted in Figure
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5.1 as in one tissue versus another. Most of the gene expression pair correlations lie
close to the diagonal line of the each plot, indicating that the marginal correlation of
the expression levels of the genes are similar across tissues. There are, however, several
points deviate from the diagonal, suggesting for these gene pairs, the correlations of
their expression levels are very different across tissues. The pattern of the marginal
correlations of the gene expressions can be viewed as an evidence of that of the gene
activities: the gene regulation network should be similar but different across tissues.
Therefore, how to use multi-tissue gene expression data to infer the gene regulation
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network to improve the efficiency is an interesting research topic in the future.
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Figure 5.1: The scatter plot of the correlations of expression levels of gene pairs in
thymus, hippocampus, spleen, spinal cord, adrenal and lung. The data is obtained
from the AGEMAP database. http://www.grc.nia.nih.gov/branches/rrb/dna/
agemap data.htm
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